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ABSTRACT
Polycyclic aromatic amines (arylamines) are a class of chemical carcinogens that
are prevalent in environmental and industrial settings. In order to study the mechanism
of their toxicity a quantitative and qualitative detection method was developed to measure
the C8-adenine adducts of benzidine and 2-aminofluorene in DNA samples. To do this a
novel synthetic method using a palladium catalyst was developed to prepare authentic
and deuterated arylamine adducts to serve as standards. These standards were then used
to develop a high performance liquid chromatography, electrospray, tandem mass
spectrometry, isotope dilution, detection method. To demonstrate the validity of this
method two spike and recovery experiments were performed.

vii

CHAPTER 1. INTRODUCTION
1.1 Background and Biological Significance
Nitrogen-containing polycyclic aromatic hydrocarbon (PAHs), including primary
aromatic amines, occur intermittently with other PAHs that are ubiquitous in the
environment and are prevalent in coal and its refined products.1 They have been used
extensively in the dye, rubber, and plastics industries, and some can be found in tobacco
smoke or in cooked foods. Both 2-aminonaphthalene and 4-aminobiphenyl may be found
in nanogram quantities in cigarette smoke and additional arylamines may be found in
amounts as high as micrograms.2 The largest industrial exposure to an arylamine may be
to 4,4’-methylenebis(2-chloroaniline) from its widespread use in the polyurethane
industry.3 2-Acetylaminofluorene was initially intended to be used as an insecticide
before it was found to be carcinogenic, and now it is the most extensively studied
arylamine.4 During the cooking process amino acids and other biologically active
molecules such as glucose and creatinine are pyrolyzed to form potent heterocyclic
arylamine mutagens. Some nitroaromatic hydrocarbons, found in diesel emissions and
other combustion products, such as wood smoke, are metabolized differently but damage
DNA by an almost identical mechanism as arylamines. The structures of some of these
compounds are presented in Figure 1. These discoveries have led to extensive research
on the mutagenicity and carcinogenicity of arylamines, including their metabolic
activation and the mechanisms of their toxicity.
Chemical carcinogenesis was first recognized over two hundred years ago in
1761, when an increase in nasal polyps was associated with an increased prolong use of
tobacco snuff.5 Fifteen years later Percival Pott noted an increase in scrotal skin cancer
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Figure 1. Structures of representative carcinogenic aromatic nitrogen compounds
among chimney sweeps, and determined that it was due to years of heavy exposure to
coal soot and tar.6 Polycyclic aromatic amines, or arylamines have been suspected
carcinogens since 1895, when Rehn documented several cases of bladder cancer among
dye manufactures, which he attributed to aniline.7 This was later determined to be from
exposure to the dye precursors of aminonaphthylenes and benzidine instead.8 The rubber
antioxidant, 4-aminobiphenyl has also been found to increase the formation of bladder
tumors in workers who have been exposed to it.9
Arylamines have indeed been found to be carcinogenic in a variety of mammals,
primarily at sites associated with their metabolism. Some of this data is summarized in
Table 1. From this table it can be seen that most of these amines form tumors in the
bladders of humans and dogs but in the livers of rodents. This is due to metabolic
activation differences that vary from species to species. It is not the actual arylamines
that causes genetic damage but activated metabolites that form covalent bonds to DNA
bases. Ironically some of the same pathways that lead to the detoxification and excretion
of some toxic substances may also lead to the formation or activation of other
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compounds. Arylamines are activated in vivo by a variety of enzymes that oxidize and/or
acetylate the amine functional group,
Table 1. Site and Species of Some Carcinogenic Arylamines
Compound

Target of Tumorigenesis

Species

Benzidine

Bladder

Humans, Dogs

Liver

Rats, Mice, Hamsters

Bladder

Humans, Dogs, Mice

Liver

Mice

Mammary gland

Rats

Bladder

Humans, Monkeys, Dogs,

4-Aminobiphenyl

2-Aminonaphthalene

Rabbits, Guinea pigs, Rats,
Hamsters

2-Acetylaminofluorene

Liver

Mice

Bladder

Dogs, Rabbits, Mice

Liver

Dogs, Rats

that goes on to form an electrophile that can covalently bond with certain bases present in
DNA.4 These bound adducts may then be responsible for mutations in the form of base
substitutions or deletions in the DNA sequence that could lead to cancer. The primary
intermediate of the activation process is an N-hydroxyarylamine that is then activated
enzymatically, or may simply be activated by protonation under acidic conditions.
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Although each arylamine is metabolized slightly differently, the generalized process is
outlined in Figure 2.
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Figure 2. The metabolic activation of arylamines
Because many of the oxidative enzymes are found in the liver, but tumors form in
the bladder, the arylamines may be oxidized in the liver and then transported to the
bladder via glucuronidation.2 It is also possible that they could actually be oxidized in
the bladder by peroxidases found there such as prostaglandin H synthase.10 Unlike 2aminonaphthalene, 1-aminonaphthalene is not carcinogenic, but its oxidized form N4

hydroxy-1-aminonaphthalene is strongly carcinogenic.2 This presents evidence that
unlike its isomer, 1-aminonaphthalene is not a suitable substrate for oxidation. In the
case of arylamides, oxidation alone is not sufficient for activation of this class of
chemicals, and they require either acyltransferase or sulfotransferase to form a reactive
electrophile.11 Often when N-acetylarylamines are administered to animals most of the
adducts detected are not acetylated. This is the case with 4-acetylaminobiphenyl and 2acetylaminofluorene.2 N-acetylbenzidine is not deacetylated, but the primary adduct that
forms is linked through the non-acetylated amine.4 While the role of acetylation in
metabolic activation is not entirely understood, a statistical correlation was found
between human bladder cancer from industrial exposure to arylamines, and the slow
acetylator phenotype of the polymorphic NAT2 N-acetyltransferase gene.12 Apparently
certain sub-populations may be at a greater risk from arylamine induced cancer than
others due to differences in their metabolic profiles. This observation was not
substantiated, however, in a later study that monitored only benzidine exposure and not a
mixture of arylamines.13 After activation to form a reactive electrophile, the arylamine
bonds to the nucleophilic sites of DNA.
The purpose of our research was to develop a detection method that is suitable to
study arylamine adduct formation in both in vitro and in vivo systems. In order to do this
it was required that we synthesize authentic and deuterated arylamine DNA adducts to be
used as standards. Once fully characterized we desired to use these standards in a high
performance liquid chromatography (HPLC), tandem mass spectrometry (MS/MS)
detection method. It was also our objective to demonstrate the validity and efficiency of
this method.
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CHAPTER 2. LITERATURE REVIEW
2.1 Arylamine Reaction Mechanisms with DNA
The most nucleophilic site among bases found in DNA is the N7 position of
guanine, which is also the site where most alkylating carcinogens bond as well.(K94) It
was originally thought that the activated electrophile, most likely a nitrenium ion, forms
an N7-arylamine adducts that is unstable and deprotonates. This creates an ylide
intermediate that undergoes a Stevens’ rearrangement to form the most prevalent C8deoxyguanosine adducts.14 This process is outlined in Figure 3.
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Figure 3. Stevens’ type N7 rearrangement
Evidence for N7 attack by a nitrenium ion is provided by a study in which C8,N9dimethylguanine was reacted with N-hydroxylaminofluorene to produce a stable N7guanyl adduct.15 NMR data from this report indicates coupling through the
aminofluorene nitrogen and the presence of a split C8 methyl group and split C8 proton
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excluding the possibility for C8 coupling. Conversely, in a different study where 8methylguanosine was reacted with N-acetyl,N-acetoxyaminobiphenyl, the researchers
reported characterizing a diastereomeric C8-guanyl adduct.16 They retain the idea of an
initial reaction at N7 but propose a different rearrangement reaction to form the C8
adduct by means of an alternate resonant structure. This mechanism can be seen in
Figure 4.
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Figure 4. An alternate N7 to C8 rearrangement
It is conceivable in the first study that it was possible to isolate the N7 adduct
because a less electron withdrawing methyl group replaced the usual deoxyribose. The
fact that different arylamines were used in each study may have also contributed to the
different results. Recently, it has been reported that nitrenium ions bond directly to the
C8 position of guanine, utilizing laser flash photolysis and kinetic data.17These authors
reacted the nitrenium ions of 2-aminofluorene and various 4-aminobiphenyls with
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solutions of deoxyguanosine. They report that the kinetics for the formation of an ylide
does not match their data for the rate of C8 deprotonation, and that an equilibrium
constant for a migration would be unreasonable, while the kinetics of the 4-amino,4’methoxybiphenyl nitrenium ion show an inverse secondary isotope effect, indicative of a
carbon changing from sp2 to sp3 hybridization. Their only comment on the low
nucleophilicity of C8 is that the intermediate ion is very stable, analogous to the
intermediates for the electrophilic substitution of benzene derivatives. Regardless of the
mechanism, the most prevalent type of adducts that form in vivo are C8 guanine adducts,
but other types of adducts form as well.
Other nucleophilic sites on bases in DNA that are capable of forming adducts are
the C8, and N6 positions of adenine, and the N2, and O6 of positions guanine. While the
C8 adenine adducts are presumably formed by a similar mechanism to the C8 guanine
adducts, the other adducts most often formed by nucleophilic addition of the base to a
resonance form of the nitrenium ion, where the charge has moved to a carbon, usually
alpha, to the nitrogen substituent. These types of adducts are formed by linkage of the
purine nitrogen to an arylamine carbon, with the exception of 1-N-hyrdoxyaminonaphthalene. This compound forms both the arylamine N-O linked adduct, N(deoxyguanosin-O6-yl)-1-aminonaphthylene and the arylamine C-O linked adduct, 2(deoxyguanosin-O6-yl)-1-aminonaphthylene.2 The formation reactions of these types of
adducts is seen in Figure 5. This is partially explained by Huckel molecular orbitalbased perturbation theory that predicts that the 1-aminonaphthalene nitrenium ion should
have more SN1 character than any other arylamine ion.18 Semiemperical AM1 molecular
orbital calculations have been used to predict which arylamine carbon is likely to be
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attacked, and while in some cases it is the carbon next to the substitution, for some larger
more conjugated amines such as 1-aminobenzo(a)pyrene, the most likely spot for reaction
may be as far as five carbons away.19
It has also been proposed that some type of stacking orientation between the
nucleoside and the arylamine may contribute to the position of adduct formation.20 The
different types of adducts formed in vivo for several arylamines are presented in Table 2.

Table 2. Structural Characterization of Arylamine Adducts.
Arylamine

C8-dG

Benzidine

Major

4-Aminobiphenyl

Major

1-Aminonaphthalene

Minor

2-Aminonaphthalene

Major

Minor
C1 linked

2-Aminofluorene

Major

Minor
C3 linked

4,4’-Metylenebis(2-chloroaniline)

C8-dA

N2-dG

N6-dA

Minor

Minor
C3 linked

Minor
C3 linked

O6-dG

Major
N linked
Minor
C2 linked
Minor
C1 linked

Major

After the adduct has formed, its structure has a profound effect on its biological
fate. Both the structure of the arylamine and the location of its binding can determine its
persistence and consequences in an organism. Acetylated 2-aminofluorene adducts are
not found in dogs and are much less persistent in rats than the non-acetylated form
because the acetylated form causes the rotation of guanine around its glycosal bond
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which adopts a syn conformation that significantly distorts DNA and may signal
preferential repair.11 This is confirmed by NMR studies of acetylated and non-acetylated
aminofluorene-dG adducts, which led to the conclusion that the non-acetylated adduct
was less distorting, and would reside in the major groove based on space filling
models.21 Conversely a recent solution conformation study of an 11-mer oligonucleotide
duplex containing a non-acetylated 2-aminofluorene C8-dG adduct opposite a deletion
site, found that the arylamine intercalates into the deletion site and that the guanine is
modified to the syn alignment.22 The presence of the deletion site and the brevity of the
11-mer oligonucleotide may explain why these results differ from earlier data.
Seven days after a single dosing of 2-aminonaphthalene, C8-dG adducts can still
be found in the bladders of dogs, where tumors occur, but the adducts can no longer be
found in the liver where tumors are rare.23 The prevalence of this adduct suggests that it
is the 2-aminonaphthalene C8-dG adduct that is responsible for mutations. This same
study also found that the most potent bladder carcinogen in dog, 4-aminobiphenyl, was
also formed the most persistent adducts with almost no loss of C8-dG, N2-dG, or C8-dA
adducts occurring over one week. However, these adducts also persisted in the liver of
dogs where 4-aminobiphenyl does not cause tumors. From this it seems apparent that
overall binding and persistence of DNA adducts is important to carcinogenicity, but are
not the only factors that matter. It could be possible that it is actually the rarely formed
C8-dA adduct that accounts for 4-aminobiphenyl’s potency as a bladder carcinogen. It
has been proposed that it is the increase in dA binding that accounts for the increased
carcinogenicity of dimethyl-benzo(a)pyrene over its unsubstituted version.24 These
authors further theorize that dA adducts may be potent because they could cause
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mutations in the TATA box involved in initiating transcription, or the AT rich sequence
that regulates the c-mos oncogene. Irregardless of adenine adduct significance, the more
abundant C8-dG adducts have been found to cause base pair substitutions and deletions
in both bacteria and mammalian systems.14
The most studied C8-dG arylamine adducts are those of 2-aminofluorene. 2aminofluorene and N-acetyl-2-aminofluorene modified NarI restriction enzyme
recognition sequences were found to cause mutations in bacteriophage M13mp9.25 In
this system the non-acetylated adduct caused G to T transversions and G to A transitions,
while the acetylated adduct caused CG deletions. N-hydroxy-N-acetyl-2-aminofluorene
has been found to cause CG to AT transversions in the first base of codon 61 of Ha-ras,
GC to TA transversions in the first base of codon 13 of N-ras, and CG to GC
transversions in the first base of codon 13 of Ki-ras in CD-1 mice.26 Several
oligonucleotides were modified with 2-aminofluorene to test its effect on the enzymes
involved in DNA repair. Synthetic primer templates with acetylated and non-acetylated
adducts caused an increase chance of incorrect dATP incorporation by T7 DNA
polymerase opposite and immediately after the adduct.27 A 2-aminofluorene adduct on a
transcribed strand caused a weak pause by RNA polymerase II, and an acetylated adduct
caused an absolute block.28 Either type of adduct located on the nontranscribed strand
enhanced polymerase arrest at a nearby sequence specific pause. The heterodimer
hMutSα, which participates in strand-specific mismatch repair, specifically binds to both
types of 2-aminofluorene adducts as well.29 Differences in the types of mutation brought
about by the acetylated or nonacetylated adducts are attributed to their conformational
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structures. It is commonly thought that sequence around the adduct and the repair system
of the organism effect the type of mutations that occur.
2.2 Synthesis of Arylamine Adducts
In order to study the mechanism of arylamine carcinogenicity, their DNA adducts
have been prepared synthetically so that they could be characterized structurally, and
used as standard references in qualitative and quantitative detection methods. As
mentioned previously, they have also been prepared in order to measure their effect on
different enzymes. This has usually been done by reacting an activated form of the
arylamine, with either whole DNA, an oligonucleotide, or single nucleosides. These
methods are limited however, because the activated forms of the arylamines are often
unstable, they react in low yield, and extensive purification is often required.
Consequently, alternate synthetic methods have been developed. One of these methods
creatively employs a base analog and multiple steps to synthesize C8-G adducts, while
other approaches rely on nucleophilic substitution of protected 8-bromoguanosine by the
arylamine. Recently these types of substitution reactions have been greatly improved by
the use of palladium catalysts.
2.2.1 Adduct Synthesis by Activated Arylamine Pathways
Traditionally DNA adducts have been prepared by methods that mimic their
biological formation. Here, the activated arylamine, usually a hydroxy or acetoxy
arylamine, is incubated with some source of DNA bases in an acidic buffer solution
around pH 5, that produces the same type of adducts in vitro that are produced by in vivo
exposure. Hydroxyl amines will not usually react with single nucleosides and
nucleotides, but they will react in vitro with whole DNA.14 Acetoxy amines will react
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with nucleosides and nucleotides but react faster with DNA. This is attributed to
electrostatic attraction between the activated nitrenium ion and the anionic phosphate
backbone of DNA.30 Also, acetoxy amines will usually form C8G adducts exclusively
with single bases and a mixture of adducts with DNA.16 This further supports the idea
that the structure of DNA itself is important for adduct formation in vivo. The hydroxy
and acetoxy compounds are most often made by partial reduction and acetylation of the
corresponding nitro compound. The three most common routes for nitro reduction and
acetylation are outlined in Figure 6.
The first hydroxylamines of this type were synthesized by the general method
developed by Willstatter and Kubli in 1908.31 This method uses a saturated solution of
NH3 and H2S to reduce the corresponding nitro compound to a hydroxylamine. This
procedure was adapted and used to synthesize N-hydroxy-2-aminofluorene in 1963,32 and
then slightly improved two years later by replacing a difficult anaerobic extraction with
precipitation and centrifugation.33 Average yields of hydroxyl amine were 65%. Several
studies have used this method21,34,35,36 to prepare N-hydroxy-2-aminofluorene that was
then reacted with deoxyguanosine, deoxyguanosine 5’-phosphate, a G containing
decamer, or whole DNA. Yields of adducts for the nucleoside and nucleotide were 15
and 5% respectively, after recrystallization with 2:1 isopropyl alcohol/water. Yields of
the decamer were similar after purification by reverse-phase C18 HPLC. The reaction
performed with whole DNA yielded roughly one adduct per 15 bases after enzymatic
hydrolysis, Sephadex LH20 chromatography, and reverse-phase C18 HPLC.
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Figure 6. The reduction and acetylation of nitro compounds
An alternate method of reduction uses hydrogenation with palladium charcoal and
acetic anhydride in ethyl acetate.37 This method will produce either an acetoxy or
hydroxy-amide. If the hydroxy-amide is desired rather than the acetoxy-amide, 1N
NaOH in 25% ethanol can be used to perform the hydrolysis. The reported yield of
hydroxy-amide by this method is only 20-30%. This method has been used to prepare Nhydroxy-N-acetyl-2-aminofluorene that was reacted with deoxyguanosine to produce
adducts that where then used to synthesize site modified oligonucleotides.29,38 Yields of
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adducts in these studies were not mentioned, but the oligonucleotides were prepared on
the pmol. scale.
A similar reduction also uses palladium charcoal, but with hydrazine hydrate as
opposed to hydrogenation.39 Here the nitro compound is dissolved in tetrahydrofuran
with palladium charcoal at 0 oC and hydrazine hydrate is slowly added. Hydroxyl amines
may be isolated by filtering to remove the catalyst, washing with sodium acetate buffer,
and then drying with MgSO4 followed by evaporation of the organic solvent. Many
hydroxyl amines are extremely sensitive to aerobic oxidation and must be handled in an
inert atmosphere. Hydroxy-amides are prepared by adding triethylamine, then acetyl
chloride in tetrahydrofuran prior to work up by neutralization with NaHCO3, extraction
with 0.1 M NaOH, washing with ether, and then precipitating with concentrated HCl.
Yields for this method are reported as 65-88% depending on nitro compound used. This
method was used to prepare hydroxyl amines and amides of 4-aminobiphenyl, 4,4’methylenedianiline, and 2-aminofluorene.25,40.41.42 These hydroxyl amines and amides
were then reacted with different types of bases to produce adducts in less than 5% yield
after extensive HPLC purification. One paper in particular used hydroxyl amines
prepared in this way to synthesize adducts in a relatively high yield.43 A solution of Nhydroxy-aminofluorene (0.1mM) was incubated with dG (5mM) in a 10 mM potassium
citrate, 0.1 mM EDTA buffer in the presence of acetylsalicylic acid (10m M). The
acetylsalicylic acid reacts with the hydroxylamine at neutral pH to form the nonacetylated adduct in 84% yield measured by HPLC. This yield is equal to that of the
reaction done without acetylsalicylic acid at pH 5. As the reaction was done on a 1.5 ml
scale, roughly 60 µg of adduct was produced.
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Depending on the type of adducts desired, N- and O- acetylation can be
incorporated into the nitro reduction, or O- acetylation can be performed on an isolated
hydroxyl amine or amide. O- acetylation can be directly performed on a hydroxyl amine
with acetyl cyanide at –40oC in tetrahydrofuran.44 The reaction of hydroxyl amines with
acetic anhydrides at 0oC produces the corresponding N-acetyl, O-acetoxy amine. It is
also possible to do the first N-acetylation with trifluoroacetic anhydride and then the Oacetylation with acetic anhydride and the resulting adducts produced from this material
and nucleosides will be non-acetylated.25,42,45 Theoretically, any gentle reductive method
that will not reduce an aromatic nitro compound completely to an amine could be used.
One reference formed N-hydroxy-1-aminopyrene in situ from its nitroso form during the
DNA incubation by including ascorbic acid. Numerous references have produced DNA
adducts by these methods using hydroxy and acetoxy compounds obtained as gifts or
from commercial sources.22,27,46,47,48
These reductive methods activate the nitro compounds by converting them to a
reactive species that goes on to form the DNA adducts. It is generally agreed that the
reactive species is a nitrenium ion.30 The hydroxy and acetoxy amines generate this
nitrenium ion in acidic solutions by a dissociative process called solvolysis but they can
also be made photochemically from the corresponding azide.17,40 All synthetic methods
that go through this route are plagued by difficulties in generating an unstable oxidation
state and then further difficulties by competitive side reactions of the nitrenium ion.
Consequently, overall yields are low, less than 5% on average, and extensive purification,
usually by HPLC, is required.
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2.2.2

Alternate DNA Adduct Synthetic Pathways
Because of the low yield of adducts prepared directly from nitrenium ions, other

types of syntheses have been explored. The most involved of these is a multistep method
that couples modified arylamines with base analogs and then converts them to N-(purin8-yl)arylamine adducts. The other synthetic method used to prepare C8-G arylamine
adducts does so by the nucleophilic substitution of 8-bromoguanosine 2’, 3’, 5’-triacetate.
While each method has been used with limited success, each has its own limitations.
The multistep synthetic method has been used to prepare C8-G and C8-A adducts
of the ortho, meta, and para isomers of toluidine also known as methylaniline.49 Guanine
adducts are made by reacting 6-hydroxy-2,4,5-triaminopyrimidine sulfate with either the
dithiocarbamate or isothiocyanate of toluidine to form a thiourea. This compound is then
either oxidized with HgO to create a carbodiimide, or methylated with CH3I to create a
methylisothiuronium ion. The carbodiimide and methyl-isothiuronium ion can then both
be cyclized thermally to create the final adduct. This scheme is outlined in Figure 7.
Adenine adducts have been prepared by using 4,5,6-triaminopyrimidine sulfate
instead of 6-hydroxy-2.4.5-triaminopyrimidine sulfate. Overall yields were reported of
approximately 12% using HgO, and 38% using CH3I. The authors did not address the
selectivity of the amine in the 5 position of the pyrimidine compounds to form the
thiourea but they did characterize their compounds by NMR and did not report any side
reactions. Although these authors prepared roughly 25 mg of each adduct and suggested
that their method would be applicable to higher arylamine homologs, there is little if any
evidence in the literature for other successful uses of this method.
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Figure 7. Multistep synthesis of C8-G adduct
Nucleophilic substitution reactions have been used to prepare C8-G adducts of
both aniline and 2-aminofluorene on a relatively large scale. This method was first used
in 1967 to prepare C8-G 2-aminofluorene adducts.34 In this approach, 8-bromoguanosine
2’,3’,5’-triacetate and 2-aminofluorene in isopropyl alcohol, were sealed in a thick walled
glass tube and heated to 150 oC for 20 hours. The tube was opened and the precipitate
that formed was hydrolyzed to the base adduct with 1:1 ethanol/1N HCL. The adduct
was then precipitated by adding aqueous 1N HCl and recrystalized with 9:1 95%
ethanol/concentrated HCl for a yield of 23%. This method was then employed to make
C8-G adducts of aniline because they could not be made from any form of hydroxy or
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NH2

acetoxy aniline.50 These authors discovered that depurination would occur above 100 oC
and that it was unavoidable with the less stable acetylated 8-bromodeoxyguanosine.
They further found that 8-bromoguanine was unreactive alone, but that the addition of
HBr or the HBr salt of the arylamine catalyzed the triacetyl-8-bromoguanosine reaction.
This was presumably due to protonation of the N7 of guanosine activating it to both
substitution and glycosyl cleavage. Rather than hydrolyze to the guanine adduct with
acid these authors deacetylated it in 1:1 methanol/0.2 M NaOH. This improved HBr salt
method was then used to synthesize the C8-G adduct of 2-aminofluorene in roughly 60%
yield.51 These authors also deacetylated under basic conditions but then utilizing a
variety of protective chemistry converted the guanosine adduct to the deoxyguanosine
adduct greatly reducing the overall yield to only 5-8%. Nonetheless, they prepared gram
quantities of adduct. Their reaction scheme is presented in Figure 8. These same authors
later demonstrated that all forms of C8-G arylamine adducts will decompose in aerobic
alkali conditions therefore, alkali hydrolysis is inappropriate for isolation of arylamine
DNA adducts in vivo.(J94,Shinyap3)
In order to prepare large amounts of C8 adducts both the multistep and
substitution methods have been used. The multistep method has been used for both C8-G
and C8-A adducts of toluidine, with overall yield less than 40%, but only produces free
base adducts without a ribose or deoxyribose present. This method does not appear often
in the literature as well, possibly indicating that it is difficult to repeat. The substitution
method has been used to produce C8 triacetylated guanosine adducts of aniline and 2aminofluorene in good yield. These adducts could then be deacetylated, also in high
yield, but conversion to deoxyguanosine adducts greatly reduced the yield. Compared to
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activated intermediate syntheses these methods offer advantages, but they themselves are
still plagued with difficulties.
2.2.3 Adduct Synthesis by Palladium Catalysis
In the last two years several attempts have been made to improve on the
substitution method by using palladium catalysts. N2-G, N6-A, and more recently C8-G
adducts have been prepared by carbon-nitrogen bound formation using the
Buchwald/Hartwig catalytic system. When factoring in the protective chemistry overall
yields are around 40% but the methods are reliable and work for a variety of arylamines
including some prone to difficult adduct synthesis.
The Buchwald/Hartwig catalysis has numerous applications for the formation of
carbon-nitrogen bounds.52,53 In general, a palladium complex is used to catalyze the
substitution of an aryl halide or triflate (trifluoromethanesulfonyl) with a primary or
secondary amine. The source of palladium is usually Pd(OAc)2 (palladium acetate) or
Pd2dba3 (tris(dibenzylideneacetone)dipalladium), and while numerous ligands have been
used to create the catalysts, the most common used have been DPPF (1,1’-bis(diphenylphosphanyl)ferrocene) and BINAP (2.2’-bis(diphenylphosphino)-1,1’binaphthyl). The catalytic cycle is presented in Figure 9.
Once the chelated palladium catalyst has been formed oxidative addition of the
aryl halide occurs. The amine then joins the complex, followed by removal of the halide
anion with base, and reductive elimination of the product to regenerate the catalytic
species. It has been found that if Pd(OAc)2 is used as a source of palladium it must be
premixed with BINAP before addition of the base or formation of the catalyst will be low
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Figure 9. The Buchwald/Hartwig catalytic cycle
leading to slow poor yield reactions.54 Specific application of this catalytic method for
the synthesis of arylamine adducts did not occur until 1999.
The first adducts prepared using a palladium catalyst were a series of N6
deoxyadenosine analogues made from reacting protected 6-bromodeoxyadenosine with
several arylamines including 2-aminofluorene and 4-aminobiphenyl.55 The resulting
adducts that formed were not really arylamine adducts but N6 aryl adducts that are not
found in vivo. From examining the literature, they found a new electron rich ligand
reported to accelerate oxidative addition of aryl heteroatom halides.56 This ligand, 2dicyclohexylphospino-2’-(N,N-dimethylamino)biphenyl gave improved yields over
BINAP. These authors also found that K3PO4 was an ideal base to use as NaOtBu caused
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decomposition and Cs2CO3 resulted in decreased reaction rates. This method is presented
in Figure 10. Yields for the different adducts ranged from 52-72%.
N2 Deoxyguanosine and N6 deoxyadenosine adducts of 2-aminonaphthalene, 2aminofluorene, 4-aminobiphenyl, and o-toluidine were prepared by reacting the exocyclic
amine of a purine with a bromine or triflate strategically placed on an aromatic nitro
compound and then reducing.57 These authors found no problems with using Cs2CO3 as
the base or BINAP as the ligand, but noted that O6 benzylation of guanosine was
required. They reported overall yields for coupling through deprotection of 70-88% for
the most part. Their reaction scheme is presented in Figure 11. In some cases the
coupling was so strong that two halides or triflates would join to the purine amine.
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Figure 10. N6 Aryl adduct synthesis with palladium catalyst
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Figure 11. N2 Arylamine adduct synthesis with palladium catalyst
Personal communication with Dr. Johnson confirmed that they had no success coupling
either protected 8-amino-deoxyguanosine with 2-bromofluorene, or protected 8-bromodeoxyguanosine with 2-aminofluorene.
More recently C8-deoxyguanosine adducts for several arylamines have been
prepared.58 These authors were able to synthesize the C8-deoxyguanosine adduct of the
food mutagen IQ (2-amino-3-methylimidazo[4,5-f]-quinoline), a compound not amenable
to other types of syntheses, in 32% overall yield from 8-bromo deoxyguanosine. In the
case of IQ, the reaction was optimized by protecting both the carbonyl and amine of 8bromodeoxyguanosine and using the strong base LiHMDS (lithium
hexamethyldisilazide). They also prepared protected C8-deoxyguanosine adducts of 4aminobiphenyl, 2-aminofluorene, and 2-aminonaphthalene in 50-60% with slightly
different conditions. In this case they found amine protection as a bis-BOC better than
the use of STABASE (tetramethyldisilyazacyclopentane) and that K3PO4 was a better
base than LiHMDS. They found no difference in yield weather using BINAP or the
ligand 2-dicyclohexylphosphino-2’-(N,N-dimethylamino)biphenyl for the arylamines.
Their reaction scheme is outlined in Figure 12.
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These recent papers utilizing palladium catalysts offer improved yields and ease over
previous methods for the synthesis of arylamine adducts. They are also capable of
making both C8 and N2 deoxyguanosine adducts as well as N6 deoxyadenosine adducts.
2.3 Detection and Quantitation of DNA Adducts
Because adduct formation occurs at extremely low levels in vivo, 1 adduct per
106- 108 bases, extremely sensitive detection methods are necessary.23 Consequently
detection has mostly been achieved by radiolabeled methods, immunoassays, or with
growing popularity mass spectrometry. All methods require some form of DNA
isolation, hydrolysis, and separation to resolve the different adducts from relatively small
tissue samples. Thin-layer chromatography (TLC), high performance liquid
chromatography (HPLC), capillary electrophoreses (CE), and even gas chromatography
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(GC) have all been used. Each method has its own strengths and weaknesses and some
references have even compared different methods to judge how well they perform on the
same samples.
Radiolabeled methods involve measuring the adducts formed from 14C or 3H
radiolabeled adduct forming compounds or by using the 32P postlabeling method. When
14

C or 3H adducts are formed they are usually analyzed by HPLC with non-labeled

synthetic, co-eluting standards added in large amounts detectible by UV. All fractions
are collected and measured for radioactivity by scintillation, and the different adducts are
identified by their retention time compared to that of the characterized standards. This is
sometimes referred to as co-chromatography. This method is limited by the high cost of
labeled compounds, the low specific activities of 14C and 3H, and the necessity of large
amounts of characterized standards for co-chromatography. The use of radio labeled
compounds may lead to confusing results due to lack of structural information. In one
case, C8-G adducts of 4,4’-methylene-dianiline were prepared and the 14C labeled
compound was administered to rats at three different dosages.41 Radioactivity was
associated with the hydrolyzed DNA but it did not elute in the fraction that eluted with
the guanosine standard. It is likely that only C8-adenosine adducts form in vivo as they
do for 4,4’-methylenebis(2-chloroaniline).59 In another study, [2,2’-3H]-N-hydroxy-4aminobiphenyl was reacted with calf thymus DNA in vitro at various concentrations.60
Radioactivity of the hydrolyzed DNA was then used as a reference to evaluate a 32P
method, an immunoassay, and an MS method. They found that at lower concentrations
adduct formation was disproportionately less than at higher concentrations but excess
radioactivity was still associated with the DNA as a non-covalently bound degradation
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product. This impurity was not found in the high concentration reactions or in vivo and is
not believed to be an adduct, but this demonstrates how because this method is not
qualitative false results can be obtained by measuring total radioactivity.
The other commonly used radiolabeled method for measuring DNA adducts is the
32

P postlabeling method. Here the adducted DNA is hydrolyzed to 3’-monophosphate

nucleotides, usually with micrococcal nuclease and spleen phosphodiesterase, and then
T4-polynucleotide kinase and [γ-32P]-ATP is used to 5’-phosphorylate the nucleotides
with radiolabeled phosphate. The next step is to separate the few labeled adducts from
the vast excess abundance of labeled non adducts. Sometimes this is eased by the fact
that T4-polynucleotide kinase will preferentially labels some adducts over regular
nucleotides. If the adduct is significantly hydrophobic, preliminary purification can be
done by C18 filtration, where normal nucleotides are removed first with water and then
the adducts are eluted with methanol. Alternately, the adducts can be enriched by
extraction into n-butanol. Final purification is then done by reversed-phase HPLC, or
more commonly by two-dimensional TLC on polyethylene-imine-cellulose plates.
Radioactivity is measured by scintillation counting of fractions for HPLC, or by
autoradiography for TLC. Sometimes Nuclease P1 is used to remove the 3’-phosphate
from the nucleotides, heightening the difference between the adducts and other
nucleotides, but this reportedly undesirably dephosphorylates C8 purine adducts.61,62
Although this method can be extremely sensitive due to the high specific activity of 32P it
is completely dependent on the efficiency of the hydrolysis, butanol extraction, and
labeling phosphorylation. Often additional experiments are required to optimize these
steps.41,63 In the previously mentioned 4-aminobiphenyl study the 32P postlabeling
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method significantly underestimated the amount of adducts, even compared to the high
concentration standards that did not contain extra radioactivity.60 HPLC has been used in
a 32P postlabeling method for the adduct of several arylamines.64 These authors report
fast analysis times at the cost of resolution compared to TLC. Overall postlabeling is
very sensitive and does not require large amounts of sample. Then again it does require
radioactive material, it is only partially qualitative by chromatography, and it is
susceptible to low recoveries.
A few types of immunoassays have been used to detect arylamine adducts. All
require that antibodies be prepared that recognize the desired DNA adducts. An
antiserum was developed that detects deoxyguanosin-8-yl-acetylaminofluorene and
deoxyguanosin-8-yl-aminofluorne but does not recognize N-acetyl-2-aminofluorene, or
any minor adducts. This serum has been used in a radioimmunoassay (RIA)65 and an
enzyme-linked immunosorbent assay (ELISA).66 The RIA works by mixing the sample
with the antibody and a radioactive standard. When the antibody antigen complex is
isolated, the sample concentration is measured by the loss of radioactivity due to the
sample displacing the labeled standard. For the ELISA test, the antigen is linked to a
polymeric support and the sample and antibody are added and then rinsed. In the absence
of sample, all antibody will bind to the standard, when it is present a proportional amount
will be removed in the wash. The amount of bound antibody is determined by a second
antibody that binds to the first, but is also attached to an enzyme that produces colored or
fluorescent products. The previously mentioned 4-aminobiphenyl study used a
dissociation-enhanced lanthanide fluoroimmunassy (DELFIA) with rabbit anti-N(guanosin-8-yl)-2-acetylaminofluorene. This antibody successfully recognized the 4-
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aminobiphenyl adduct. This type of assay is like an ELISA but has biotin bound to the
second antibody in place of an enzyme. It then uses the strongly fluorescent europiumlabeled streptavidin that binds to biotin to measure the amount of original antibody that
bonded to the fixed antigen. These authors found that the assay overestimated the
amount of adducts formed. They attributed this to the antiserum reacting more strongly
with the in vivo deoxyguanosine adducts than it did with there synthetic guanosine
standards. Immunoassays have excellent sensitivity but require antibodies that are
difficult to prepare. They also are so specific that they are not able to detect multiple
adducts, or so non-specific that they are not able to distinguish between adducts, and
possibly interferences.
Mass spectral methods have been performed with GC, HPLC, and CE used for
separation. In the specific case of arylamine adducts, GC requires hydrolysis of the
adducts with base to release the arylamines, that are then extracted, derivitzed, and
introduced into the GC. The isolated DNA can be extracted before hydrolysis to insure
that no unbound arylamines are present. This method has been used to detect 4aminobiphenyl adducts from the bladder and lung mucosa of human smokers,46 and in the
4,4’-methylenedianiline study mentioned previously. Recoveries from the hydrolysis
were 55 to 85%, and no structural forms of adducts could be identified because only the
arylamine is detected. This was fortunate in the case of the 4,4’-methylenedianiline study
because they expected deoxyguanosine adducts and did not find any, but they were able
to determine that some type of adduct had formed. Both methods used deuterated
arylamines as internal standards and confirmed their results by the 32P postlabeling
method. Drawbacks of this method include the fact that it is not qualitative, there is

30

relatively low recovery from the hydrolysis, and it is dependent on the efficiency of the
derivitization. Hydrolysis to the arylamine is required for GC because the whole adducts
cannot be volatilized into the gas phase. HPLC and CE on the other hand may be used to
analyze much larger nonvolatile compounds.
The 4-aminobiphenyl study used a complicated HPLC system with two pumps, a
trap column and an analytical column, and switches that directed the flow to either a
waste reservoir or a single quadrupole mass spectrometer. Two columns were used in
order to concentrate the sample on the trap column at a high flow rate, before loading it
on to the analytical column, which operated at a low flow rate so as to not overwhelm the
mass spectrometer. The sampling skimmer-cone was switch between low and high
voltage to produce in-source collision-induced dissociation and the selected ions of the 4aminobiphenyl adduct, its deuterated standard counterpart, and their largest fragments
were monitored. Detection of a molecular ion and a characteristic fragment ions offer
good confirmation of the identity of the analyte. Different isomers of adducts may also
be identified by their different fragmentation patterns, such as in the case of the C8-G and
N2-G adduct of 2-aminofluorene that were measured by capillary chromatography
coupled with continuous-flow fast atom bombardment tandem mass spectrometry.67 The
major fragment of the C8 adduct has a m/z of 165 and a unique secondary fragment with
m/z of 140 is also produced, while for the N2 adduct a major fragment with a m/z of 180
and a unique secondary fragment with a m/z of 222 is produced. In tandem mass
spectrometry, two mass spectrometers are used in series. The first mass filter passes only
the desired parent ions and the second selects only the desired fragments or daughter
ions. With triple quadrupole mass spectrometers the middle set of quadrupoles does not
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scan but is used as a collision cell to produce the fragments detected by the last set of
quadrupoles. Selected ion monitoring (SIM) or multiple reaction monitoring (MRM) that
only detect desired ions, offer increased sensitivity by removing background ions, thus
increasing the signal to noise ratio, and by increasing scanning time on only one or few
specific masses. This type of scanning typically makes possible adduct detection at
levels as low as 30-50 fmol.68 Because deoxynucleoside adducts usually lose their
deoxyribose when they fragment, constant neutral loss (CNL) experiments can also be
performed. In CNL scanning, all ions are detected that come from parent ions that have
lost a specific fragment, in this case a 116 dalton deoxyribose group. This method does
not offer increased sensitivity over full scan mode but it does simplify the resulting mass
chromatogram, although non-adducted nucleosides are also detected. This type of
scanning has been used to characterize an in vitro reaction of calf thymus DNA and Nacetoxy-N-acetyl-2-aminofluorene.67
This method also used CE for separation with sample stacking to improve
sensitivity. CE methods offer better separation resolution than HPLC by having less peak
broadening and more theoretical plates for analyte interaction. Sample stacking involves
concentrating dilute solutions on the front of the capillary before separation. In this case
it was discovered that a 350nl injection of a 5 x 10-6 M solution of adducts was equal to a
35nl injection of a 5 x 10-5 M solution, or a 3.5nl injection of a 5 x 10-4 M solution.
Capillary electrochromatography (CEC) has been coupled with electrospray ionization to
detect the DNA adducts of benzo(g)chrysene and 2-aminofruorene as well.69 These
authors demonstrated how stopping the electoosmotic flow mid run did not cause peak
broadening from diffusion, and mentioned that this would be ideal for ion traps where
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long data acquisition times are required to detect fragments of fragments of fragments.
Of all the methods mentioned, only mass spectrometry provides direct qualitative
information, and with sample concentrating and MRM comparable detection limits to the
other types of methods can be achieved.
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CHAPTER 3. THE SYNTHESIS OF ARYLAMINE
DNA ADDUCTS
3.1 Introduction and Objective
The overall goal of this project was to develop an HPLC, electrospray, tandem
mass spectrometry, quantitative detection method. In order to achieve this it was
necessary to synthesize deuterated and non-deuterated DNA adducts of selected
arylamines to be used as internal standards and for the construction of a quantitative
calibration curve. The synthesis of arylamine DNA adducts was attempted by numerous
routes, before a new method was developed based on work that was done with
Buchwald/Hartwig palladium catalyst. This method was successful for preparing the C8adenine adducts of several arylamines, in a few steps, and on a large enough scale for
their easy characterization by NMR. In order to lessen the cost of using deuterated
arylamines various labeling and synthetic routes from inexpensive starting materials were
also explored.
3.2 Preparation of Deuterated Arylamines
The synthesis of deuterated arylamine adducts required that large amounts of
deuterated arylamines be available for coupling. As even stable isotopically labeled
compounds are expensive, an inexpensive and efficient route for their preparation was
sought. 2-aminoanthracene (2AA) was the arylamine we were primarily interested in, as
it is similar enough to known carcinogenic arylamines, to suggest a similar toxicity, but it
is much less well studied. It is also slightly more bulky that 2-aminonaphthalene,
indicating that its DNA adducts might be more interfering and thus more mutagenic.
The first method attempted was an adaptation of the tritiation procedure
developed by Yavorsky and Gorin70 which had been used successfully on aromatic
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insecticides,71 coal by-products,72 and even arylamines.73 This procedure involves
reacting tritiated water with phosphorus pentaoxide (P2O5) to make tritiated phosphoric
acid, and then saturating the acid with BF3 gas to make a more reactive reagent. The
compound to be labeled is then introduced in a small amount of solvent that has no
exchangeable protons. Aside from acidic protons, only the aromatic protons on carbon
are exchanged by this method. For our purposes, deuterium oxide (D2O) was used
instead of tritiated water, as a compound with an altered mass was desired rather than a
radioactively labeled one.
Attempts to deuterate 2AA by this method were unsuccessful. After work up,
analysis by HPLC and APCI MS indicated only a 10% increase in the M+1 ion intensity
and a 3% increase in the M+2 ion intensity. There was also evidence of extensive
decomposition to heavier products, especially after prolonged exposure to light and
oxygen. One of these impurities, isolated by HPLC/MS had an uncommon isotopic
pattern ranging from 209 to 215 m/z compared to that of 194 for the [M+H]+ ion of 2AA.
This could conceivable be a partially deuterated, partially oxidized form of 2AA such as
2-nitrosoanthracene or 2-amino-9-anthracenone. The other impurity had a m/z of 481
and is likely to be some type of oxidized dimer. Performing the reaction without a
cosolvent or at higher temperature only increased the amounts of impurities formed.
While a roughly 10% labeling efficiency may be suitable for tritiation, successful
deuteration requires a complete exchange of at least three protons to increase the mass
above naturally occurring isotopes.
The next method attempted for the deuteration of 2AA was the high temperature
dilute acid (HTDA) method developed by N.H. Werstiuk.74,75 This involves labeling
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aromatic hydrocarbons with dilute DCl /D2O (2-4%) at temperatures between 250-280 oC
in evacuated and sealed thick walled glass tubes. Werstiuk deuterated 97% of the
aromatic protons on the hydrochloride salt of aniline by repeating this method several
times on the same material. He also found that at temperatures above 250 oC the aniline
would decompose to phenol. In our hands with 2AA this procedure caused almost
complete formation of the 481 m/z impurity found earlier with small amounts of
unlabeled 2AA remaining. 2-nitroanthracene was also tried and also decomposed for the
most part. GC/MS of the nitro reaction revealed that one of the impurities that formed
had a broad isotopic pattern centered at 293 m/z. This is 70 m/z greater than the mass of
2-nitroanthracene (223 m/z), indicating that in addition to side reactions some deuteration
was occurring.
It is believed that the mechanism of deuterium exchange for these methods is
similar to electrophilic aromatic substitution, where cationic intermediates are formed.
While amines are considered activating for aromatic substitution, in the presence of acid
they are protonated themselves, forming a cation that would discourage the addition of
any more deuterium atoms essential for exchange. This is portrayed in Figure 13. This
problem was eventually overcome by the use of a platinum catalyst.
A method developed for the deuterium labeling of aromatic amino acids76 was
modified for use with arylamines. Here Pto or Adams catalyst is mixed with D2O and the
amino acid to be labeled is added in a solution of 40% deuterated sodium hydroxide
(NaOD). The mixture is then refluxed under argon for 48 hours. Because 2AA is not
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Figure 13. Deuterium exchange of 2-aminoanthracene
soluble in NaOD deuterated ethanol (EtOD) was used instead. After five sequential
exchanges, 2AA was obtained with an isotopic pattern corresponding to a 52% exchange
of seven protons with the most intense isotope being M+4, determined by GC/MS. A
GC/MS mass spectrum of deuterated 2AA and an unlabeled 2AA reference standard are
presented in Figure 14.
Compared with substituted compounds, deuterated polycyclic aromatic
hydrocarbons are inexpensive, and it was thought that they could be used as precursors to
labeled arylamines. Fluorene is preferential nitrated in the two position and then easily
reduced to its corresponding arylamine with zinc.77 This procedure was tried first with
nonlabeled fluorene and then repeated with a different reduction,78 using per-deuterated
fluorene to synthesize d9 2-aminofluorene in 46% overall yield from d10 fluorene.
Ironically the new reduction used hydrazine hydrate and palladium carbon in refluxing
ethanol. These conditions are very similar to those used to reduce nitro compounds to
hydroxy amines, except that the temperature is kept at 0 oC rather than at a 79 oC reflux.

37

Figure 14. Mass spectrum of labeled 2-aminoanthracene and standard
This same procedure has been used at least twice before in the literature to prepare d9 2aminofluorene.79,80
Unfortunately in the case of anthracene the two positions on its central ring are
highly activated towards substitution by resonance. This is because if substitution occurs
at one of these positions the two exterior rings still maintain their aromaticity during
formation of the intermediate. This is illustrated in Figure 15. Consequently 9nitroanthracene is the only product formed upon nitration. To prevent nitration at this
position an attempt was made to nitrate 9,10-dihydroanthracene by the same method used
to nitrate fluorene. Because the 9,10 positions would no longer be aromatic they would
not be available for nitration. The product could then be easily rearomatized by
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Figure 15. The nitration of anthracene
dehydrogenation. GC/MS of the reaction revealed a mixture of three components. The
primary component produced was 9,10-anthracenedione with lesser amounts of 9anthracenone, and 9-nitoanthracene also present. Apparently the nitric acid was
oxidizing and rearomatizing the 9,10-dihydroanthracene prior to nitration.
3.3 Adduct Synthesis by Activated Arylamine
Although it was initially avoided due to the risks involved with handling an
activated carcinogen, it was eventually decided to attempt this method, as no others
seemed to work. This method requires that nitro compounds be reduced and or
acetylated and then incubated with a source of nucleosides. As 2-nitroanthracene is not
commercially available it was prepared by the oxidation of 2-aminoanthracene, which is.
The idea of preparing hydroxy amines directly from the amine by oxidation was also
briefly explored. 2-nitrofluorene was used to test the activated arylamine method. The
reduction was performed with hydrazine hydrate and palladium charcoal. The first
experiments reacted N-trifluoroacetyl,N-acetoxy-2-aminofluorene with deoxyguanosine
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monophosphate. A second method was also developed to react N-hydroxy-2aminofluorene directly with deoxyguanosine monophosphate in an inert atmosphere, and
in the presence of acetylsalicylic acid without previous isolation.
The traditional preparation of 2-nitroanthracene contains seven steps including a
Friedel Crafts reaction, a nitration and several dehydrations,81 making it long and
difficult. This scheme is presented in Figure 16.
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DDQ = 2,3-dichloro-5,6-dicyano-1,4-benzoquinone

Figure 16. The synthesis of 2-nitroanthracene

In order to avoid this, a procedure was found to prepare 2-nitroanthracene by the sixelectron oxidation of 2-AA with m-chloroperbenzoic acid.82 After flash chromatography
2-nitroanthracene was isolated in 56% yield. GC/MS of this compound showed the

40

correct mass and a unique retention time versus that of 9-nitroanthracene. Magnesium
monoperoxyphthalate was also tried as an oxidant but found to offer no advantage.83
If hydroxy amines could be prepared from their corresponding amines, it would
exclude the need for nitro compounds. The literature was examined to see how likely this
approach would be. One method reported excellent results for the synthesis of hydroxy
amines from non-aromatic amino-saccharides and the methyl esters of amino acids, using
the reagent 2,2-dimethyldioxirane.84 This method was not tried however because 2,2dimethyldioxirane is unstable and must be prepared in situ or immediately prior to use,
and it has been know to completely oxidize arylamines to their nitro counterparts.85 A
different method was found that used benzoyl peroxide to create a benzoyl amine that
would then give the hydroxylamine when treated with base.86 Aniline was chosen as a
model arylamine, but this method was abandoned after several attempts when it was
determined that the benzyl amide was being produced instead of the benzoyl
intermediate.
The reduction of 2-nitrofluorene to N-acetoxy-N-trifluoroacetyl-2-aminofluorene
appeared to go smoothly. The reaction could be followed by TLC and a FAB mass
spectrum was obtained of the product that did not contain a molecular ion, but did contain
two likely fragments as the most abundant ions. These fragments were of 292 m/z from
C-O cleavage of the acetoxy group, and 276 m/z from N-O cleavage of the acetoxy
group. After incubation with deoxyguanosine monophosphate, and acid hydrolysis,
direct HPLC/MS analysis revealed the presence of the non-acetylated C8-guanine 2aminofluorene adduct in small amounts. Tandem mass spectrometry of the molecular ion
produced the characteristic fragments seen in Figure 17.
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Figure 17. Fragments of the C8-G 2-aminofluorene adduct
These are the same fragments found by similar methods reported in the
literature.68 Attempts to isolate this compound by collecting fractions from an analytical
column did not succeed. It is possible that not enough material was collected from
subsequent runs in order to be detected, or that the wrong peaks were collected. Attempts
to purify the reaction products by chromatography on silica also failed. The direct
reaction of N-hydroxy-2-aminofluorene in the presence of acetylsalicylic acid had no
noticeable affect on yield.
3.4 Alternate Adduct Synthetic Pathways
The two alternate types of adduct syntheses previously discussed were also
attempted. The first tried was that of Swenson, that goes through a thiourea intermediate
after reacting the arylamine with 6-hydroxy-2,4,5-triaminopyrimidine. The other method
tried was the direct reaction of 2AA with 8-bromoguanosine-2’,3’,5’-triacetate. Neither
method was successful, but recent attempts at the later could be worthwhile if a suitable
HPLC purification method could be found.
Swenson’s multistep method involves converting the arylamine, which is a poor
nucleophile, into a good electrophile, and then reacting it with one of the amines present
on a guanine analog. Suitable electrophiles are either the dithiocarbamate, or the
isothiocyanate of the arylamine. When either of these compounds are reacted with 6-
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hydroxy-2’,4’,5’-triaminopyrimidine they form a thiourea linked adduct. By removing
the sulfur atom, and performing a ring closure on the intermediate, the molecule is
converted to the C8 guanine adduct. Both methods were tried without success. The
dithiocarbamate was prepared by reacting 2AA with CS2 in 30% NH4OH and
precipitating. Matrix assisted laser desorption ionization MS did not detect a molecular
ion but it might have fragmented before reaching the detector. Isothiocyanates of
arylamines were prepared by the literature procedure using the reagent 1’,1’thiocarbonyldiimidazole.87 This reaction is outlined in Figure 18.
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Figure 18. The isothiocyanate preparation of arylamines

The isothiocyanates of 2AA, 2-aminofluorene, and 2-aminonaphthalene were prepared in
82-90% yield and confirmed by GC/MS. Coupling of the dithiocarbamate of 2-AA or
any of the isothiocyanates with 6-hydroxy-2,4,5-triaminopyrimidine were unsuccessful.
NMR indicated more peaks than were expected for the product, and incomplete
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conversion of starting material. FAB MS did not indicate product formation either.
HPLC purification and analysis by ESI-MS were also unsuccessful.
The first attempt at coupling an arylamine with 8-bromoguanosine-2’,3’,5’triacetate was based on the early procedure reported by Kriek et al34 The components
were dissolved in a small amount of isopropanol and sealed in glass tube. After heating
the tube was opened and the solid inside was washed with methanol and then hydrolyzed
in ethanol/1N HCl. This was then precipitated with additional HCl. This precipitate was
purified by HPLC but no fractions were found to contain product by ESI-MS. No
improvement was found by repeating the reaction at atmospheric pressure in DMSO.
When it was discovered in the literature that this reaction is acid catalyzed, the
hydrobromide of 2AA was prepare and the reaction was tried once more in refluxing
isopropanol. Online HPLC/MS revealed the formation of completely hydrolyzed product
in relatively large amounts. Preparative HPLC succeeded in slightly purifying this
compound but was never optimized. Since depurination was intended for the adduct
anyway, in this case cleavage of the glycosidic linkage was actually an advantage.
3.5 Adduct Synthesis with Palladium Catalysis
Recently the use of palladium catalysts for the formation of similar adducts
indicated it might be possible to use them to make C8 adducts in high yield. After
reviewing the literature for the Buchwald/Hartwig catalysis, a method for the coupling of
a substituted 2-chlorobenzimidazole with a primary alkylamine was selected as a starting
point for synthesis of C8-guanine adducts.88 This scheme is outlined in Figure 19.
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Figure 19. Palladium catalyzed amination of a chloroimidazole

It was decided to begin with the reaction of aniline and 8-bromo-adenosine as a
simplified model for the desired reaction. This was because aniline is the simplest and
smallest arylamine and adenosine offers improved solubility over guanosine and does not
contain a reactive carbonyl functional group. The modified reaction we developed is
outlined in Figure 20.
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Figure 20. Coupling of protected adenosine and aniline

While 8-bromo-adenosine and 8-bromo-guanosine are both commercially
available and relatively inexpensive for modified nucleosides, the reactivity of the
hydroxyl groups on the purine ribose requires that they be protected. Tertbutyldimethylsily groups are ideal for this and are commonly used. 8-Bromo-adenosine
is easily silylated and purified by the conventional method89 used for unsubstituted bases,
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but 8-bromoguanosine is slightly harder to purify due to its increased polarity. 8-Bromo2’,3’,5’-tris-O-(tert-butyldimethylsilyl)-adenosine was prepared in 96.7% yield and 8brono-2’3’5’-tris-O-(tert-butyldimethylsilyl)-guanosine in 80.1%. The reaction proceeds
rapidly with only trace amounts of mono- and di-protected species forming. These minor
impurities are easily separated by flash chromatography. Due to steric hinderence, each
of the six silyl methyls has a unique 1H NMR frequency, as do the three t-butyl groups.
This is seen in Figure 21.

Figure 21. 1H NMR spectrum of protected 8-bromo-adenosine

The coupling with aniline proceeded smoothly, giving product in 84% yield. 1H
NMR of this adduct indicates success by the relative integration of the aromatic protons
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and reasonable shifting of the amine peaks. The ribose protons are also shifted and split
in a characteristic fashion found in all other adducts made. This can be seen in Figure 22.

Figure 22. 1H NMR spectrum of the aniline-adenosine adduct

Unfortunately, coupling with the larger arylamines, 2-aminoanthracene and 2aminofluorene, were low yielding and difficult to purify. Different reaction conditions
were tried, using alternate ligands, bases, and solvents to improve yield, while different
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solvent mixtures were tried to improve isolation by flash chromatography on silica gel.
Aside from BINAP two additional ligands were tried. The ligand 2dicyclohexylphosphino-2’-(N,N-dimethylamino)biphenyl was used by Lakshman for his
N6-aryl-adenosine adducts, and the other ligand, 2-(Di-t-butylphosphino)biphenyl, was
developed by the Buchwald group to improve the coupling of primary anilines with
electron rich aryl bromides. Both ligands are recently available from Strem Chemicals.
The results of several reactions for the coupling of 2-aminofluorene with protected 8bromo-adenosine are presented in Table 3.
The biphenyl ligands did not perform as well as BINAP and choice of base
seemed to have no effect. The conditions of Lakshman were designed to improve the
solubility of the mild base K3PO4, but they were found ineffective and no noticeable
degradation of the nucleoside was found to occur from the harsher base NaOtBu. 3:1
Hexane/ethyl acetate was sufficient for chromatography of the aniline adduct, but it did
not work for any of the others. 5% acetone/dichloromethane, used by Lakshman, also did
not work but 5% methanol/chloroform was successful in isolating the benzidine adduct in
60% yield. This mixture was too polar to isolate the 2-aminofluorene, and 4aminobiphenyl adducts, but 0.5% methanol/chloroform was used to purify them in 28%,
and 26% respective yield. It is possible that the low polarity of this solution prevents
recovery of the entire amount of compound from the silica, but it is required for the sake
of purity. This problem is exacerbated by the high catalytic loading (30 mol % Pd, 50
mol % BINAP) that we found was needed for complete loss of starting material. The
coupling of 2AA was even poorer yielding and a suitable procedure for isolation was not
found, although HPLC/MS of the crude reaction indicated some product was formed.
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Table 3. Reaction Coupling Conditions
Solvent

Pd2(dba)3

Ligand

Base

Results

1,2-Dimethoxyethane

10 mol %

30 mol % L1

K3PO4

No Reaction2

Toluene

10 mol %

30 mol % L1

Cs2CO3

<30 % Crude Yield

Toluene

10 mol %

30 mol % L3

NaOtBu

No Reaction

Toluene

10 mol %

30 mol %
BINAP

K3PO4

<30 % Crude Yield

Toluene

10 mol %

30 mol %
BINAP

Cs2CO3

<30 % Crude Yield

Toluene

10 mol %

30 mol %
BINAP

NaOtBu

<30 % Crude Yield

P(C6H11)2

L=

(Me)2N

1.

2. Conditions used by Lakshman55
P(t-Bu)

L=

3.
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When palladium acetate (Pd(OAc)2) was used as a source of palladium instead of
tris-dibenzlideneacetone-di palladium (Pd2(dba)3 faster reaction times were observed but
yields did not improve. Typical reactions with Pd(OAc)2 showed a complete loss of
starting material after 6 hours, while those with Pd2(dba)3 took 8-24 hours. Pd(OAc)2 did
require premixing with the ligand before addition of the base, because base was found to
prevent formation of the active catalyst.54 To determine if the chirality of BINAP had
any effect on coupling, the reaction of aniline and protected adenosine was tried
separately with either R or S-BINAP as opposed to the usual racemic mixture. Yield was
determined by HPLC and was found to be 77% for R-BINAP and 87% for S-BINAP,
indicating that chirality had little or no effect. A possible explanation for this is that the
C-N bond that is formed is not chiral itself, or that the stericly hindering chiral parts of
the BINAP and the nucleoside are too far away from the active site of the catalyst to
control bond formation.
Attempts to couple 2-chloroaniline, 4-chloroaniline, or 3,3’-dichlorobenzidine
with protected adenosine were mostly unsuccessful although some crude NMR spectra
indicated that product might be forming in low amounts. These compounds all have
halides attached to them however, and this offers a site for self-polymerization, where the
amine couples at a chlorine position on a similar molecule, rather than at the bromine
position on a nucleoside molecule. 8-Bromo-adenosine also has an amine that allows for
this type of side reaction, but it has been found that the reactivity of the amine is key for
this reaction to proceed.90 Johnson has demonstrated that these types of dimers or even
trimers are possible to create but that the N2 of guanosine is much more reactive than the
N6 of adenosine. This is illustrated in Figure 23.
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Figure 23. Nucleoside to nucleoside coupling

In spite of these results no adenosine dimer or polymer was detected and protection of the
adenosine amine was not required. Alternately, 8-bromo-2’,3’,5’-tris-O-(tbutyldimethylsily)-guanosine would not couple with any arylamine most likely due to
interference from its amine and carbonyl functionalities interacting with the catalyst.
Overall, four arylamine adenosine adducts were prepared. These compounds
were characterized by 1H and 13C NMR, IR, high-resolution mass spectrometry, and
HPLC/ESI mass spectrometry. The deuterated versions of two of these arylamines were
also prepared. The yields of these reactions are summarized in Table 4.
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Table 4. Arylamine-Adenosine Adduct Yield

Arylamine

% Yield

Aniline

84

Benzidine

60

4-Aminobiphenyl

28

2-Aminofluorene

25

d8 Benzidine

28

d9 2-aminofluorene

26

Although these yields are not exceptional they are much higher than those reported for
nitrenium ion methods, and they allow for the easy preparation of large amounts of
material for use or NMR analysis. The authentic and deuterated benzidine and 2aminofluorene adducts where hydrolyzed with HCl and used as standards for a
quantitative HPLC tandem mass spectrometry detection method.
The adducts were hydrolyzed by dissolving in ethanol, adding an equal amount of
1 N HCl and refluxing for 1 hour. The ethanol was then removed under reduced pressure
and the solution, along with any precipitate, was loaded onto a C-18 Sep-Pak cartridge.
It was then washed with water and eluted with two 5ml portions of acetonitrile and one of
methanol. This elution worked for the benzidine adduct which came off in the methanol,
but the 2-aminofluorene adduct came off in the first acetonitrile fraction and was impure.
This was overcome by eluting with 20%, 40%, 60%, 80% and 100% mixtures of
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acetonitrile in water. The first three fractions contained the 2-aminofluorene adduct free
from impurities. These adducts were then used to develop an analytical method.
3.6 Experimental
Dry DMF and toluene were purchased from ACROS in septum capped bottles and
used as such. All other solvents used were ACS grade or higher. All reactions were
performed under an atmosphere of argon. R-, S-, and racemic BINAP, 2dicyclohexylphosphino-2’-(N,N-dimethyl-amino)biphenyl, and 2-(di-tbutylphosphino)biphenyl were purchased from Strem, Newburyport MA and used as
received. All other compounds were purchased from Aldrich and used without further
purification except for 2-aminofluorene that was recrystalized once from 50% aqueous
ethanol. Analytical thin layer chromatography was performed using Alltech pre-coated
silica gel UV/254 plastic plates. Compounds were visualized by dipping the plates in a
KmnO4 solution and then rinsing with DI water. Flash column chromatography was
performed using the indicated solvent on Scientific Adsorbents Inc. silica gel (32-63 mm,
Atlanta GA). IR spectra were recorded in dichloromethane on salt plates using a Bruker
Equinox 55 spectrometer. 1H and 13C NMR were recorded in CDCl3 using a JEOL
Eclipse 400 FT NMR spectrometer. HRMS was performed by Pharmacia.

2-Aminoanthracene-d7
A 50 mL Schlink flask was flushed with argon and charged with 100 mg of Pto
and 10 mL D2O. 200 mg of 2-aminoanthracene dissolved in 15 mL of EtOD was then
added and the mixture was refluxed for 48 hours under argon. After cooling the mixture
was filtered and washed with 3 x 10 mL of DCM. The organic phase was then washed
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with 3 x 20 mL of water and the concentrated under vacuum. The reaction was repeated
four more time with fresh Pto and D2O. The final product was then analyzed by GC/MS.

2-Nitrofluorene-d9
Prepared by the literature route using fluorene-d10. (Khun, W. E. Organic
Syntheses, Coll. Vol. 2, 1933, 447) Analyzed by GC/MS.

2-Aminofluorene-d9
Prepared by the literature route using 2-nitrofluorene-d9. (Bavin, P. M. Organic
Synthesis, Vol. 40, 1960, 5.) Analyzed by GC/MS.

2-Nitroanthracene
Oxidized form 2-aminoanthracene by the literature procedure using mchloroperbenzoic acid. (Scribner, J. D.; Fisk, S. R.; Scribner, N. K. Chem-Biol.
Interactions 1979, 26, 11.) Analyzed by GC/MS.
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8-bromo, 2’,3’,5’-tris-O-(tert-butyldimethylsilyl)-adenosine
Prepared by a modified literature procedure.(Ogilvie, K. K.; Beaucage, S. L.;
Scifman, A. L.; Theriault, N. Y.; Sadana, K. L. Can. J. Chem. 1978, 56, 2768-2780) For
a typical reaction, an oven dried Schlenk flask that was cooled under vacuum, flushed
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with Argon, and charged with 8-bromo-adenosine (300 mg, 0.87 mmol) and imidazole
(473 mg, 6.96 mmol). Dry DMF (5 mL) was added via syringe followed by tertbutyldimethylchlorosilane (525 mg, 3.48 mmol). The system was flushed once more
with Argon and allowed to stir at room temperature for 24 h. TLC showed one major
spot (rf 0.65) followed by two minor ones (rf 0.51, 0.46). (10 ml) Water was then added
and the product was extracted with CHCl3 (3 x 30 mL).

The combined organic layers

were washed once with saturated NH4Cl, twice with brine, and then dried over MgSO4.
The drying agent was removed by filtration and the solvent was evaporated to leave a
white powder. The crude material was purified by flash chromatography (3:1
hexane/EtOAc) affording first the title compound (512 mg, 86%) and a mixture of the
mono and di protected nucleoside(64 mg, 11%). IR 3331, 3187, 2928, 2856, 1668, 1604,
1576, 1458, 1146, 1055, 779, 335 cm-1; 1H NMR (CDCl3) d 8.25 (s, 1 H), 5.94 (d, J = 5.5
Hz, 1 H), 5.55 (bs, 2 H), 5.50 (dd, J = 4.4, 5.8 Hz, 1 H), 4.57 (dd, J = 2.2, 4.4 Hz, 1 H),
4.07 (m, 2 H), 3.71 (m, 1 H), 0.96 (s, 9 H), 0.83 (s, 9 H), 0.79 (s, 9 H), 0.16 (s, 3 H), 0.15
(s, 3 H), 0.02 (s, 3 H), -0.02 (s, 3 H), -0.07 (s, 3 H), -0.35 (s, 3 H);

13

C NMR d 154.2,

152.7, 151.0, 129.0, 120.6, 90.7, 85.7, 72.3, 71.8, 62.3, 26.0, 25.9, 25.8, 18.4, 18.2, 17.9,
-4.4, -4.5, -5.1, -5.3, -5.5. Elemental analysis for C28H54BrN5O4Si3 calculated 48.82% C,
7.90% H, 10.17% N, found 49.01% C, 7.77% H, 10.22% N. HRMS calculated for (M+ +
1): 688.2745, found: 688.2757.
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N-(2’,3’,5’-tris-O-tert-butyldimethylsilyladenosin-8-yl)-aniline
Prepared by a modified literature procedure (Hong, Y.; Tanoury, G. J.; Wilkinson,
H. S.; Bakale, R. P.; Wald, S. A.; Senanayake, C. H. Tetrahedron Letters, 1997, 38,
5607-5610. For a typical reaction, an oven dried Schlenk flask and condenser was cooled
under vacuum, flushed with Argon, and charged with 8-bromo-2’,3’,5’-tris-O-(tertbutyldimethylsilyl)-adenosine (20 mg, 0.03 mmol), Pd2(dba)3 (0.4 mg, 1.25 mol%),
BINAP (0.7 mg, 3.75 mol%), aniline (3.6 mL, 0.039 mmol), NaOtBu (4.04 mg, 0.042
mmol), and anhydrous toluene (5 mL). The temperature of the orange solution was
brought to 80 oC using an electronically controlled oil bath. After 6 h all starting material
was consumed (TLC). The solution was transferred to a round bottom flask and the
solvent was evaporated. The crude mixture was purified by flash column
chromatography (gradient 3:1 hexane/EtOAc, to 1:1 hexane/EtOAc, rf 0.08) which
afforded the title compound as a purple solid (17.6 mg, 84%). IR 3353, 3160, 2957,
2929, 2858, 1662, 1639, 1599, 1556, 1470, 1255, 1165, 1103, 829, 774 cm-1; 1H NMR d
8.19 (s, 1 H), 7.70 (s, 1 H), 7.49 (bd, J = 7.7 Hz, 2 H), 7.34 (dd, J = 7.7, 7.7 Hz, 2 H),
7.09 (dd, J = 7.7, 7.7 Hz, 1 H), 6.16 (d, J = 7.0 Hz, 1 H), 5.48 (br, 2 H), 4.82 (dd, J = 4.6,
7.1 Hz, 1H), 4.26 (dd, J = 2.2, 4.8 Hz, 1 H), 4.16 (bd, J = 2.2 Hz, 1 H), 4.05 (dABq, J =
2.2, 11.7 Hz, 1 H), 3.87 (dABq, J = 2.6, 11.7 Hz, 1 H), 0.95 (s, 9 H), 0.83 (s, 9 H), 0.72
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(s, 9 H), 0.15 (s, 3 H), 0.10 (s, 3 H), -0.01 (s, 3 H), -0.07 (s, 3 H), -0.08 (s, 3 H), -0.31 (s,
3 H);

13

C NMR d 152.4, 150.3, 148.7, 139.0, 129.0, 123.4, 120.8, 117.3, 86.5, 86.4, 72.5,

72.1, 63.1, 29.8, 26.2, 26.0, 25.6, 18.8, 18.2, 17.8, -4.3, -4.5, -4.6, -5.1, -5.2, -5.4. HRMS
calculated for (M+ + 1): 701.4062, found: 701.4056.

NH 2
N

N

NH
N

N
OTBS
O
TBSO

OTBS

N-(2’,3’,5’-tris-O-tert-butyldimethylsilyladenosin-8-yl)-4-aminobiphenyl
Prepared by the same procedure as the N-(2’,3’,5’-tris-O-tertbutyldimethylsilyladenosin-8-yl)-aniline, using 8-bromo-2’,3’,5’-tris-O-(tertbutyldimethylsilyl)-adenosine (40 mg, 0.06 mmol), and 4-aminobiphenyl (30.4 mg, 0.18
mmol). 30 Mol% Pd2(dba)3, and 50 Mol% BINAP were used. The product was purified
by flash chromatography (1% MeOH /CHCl3, rf 0.21) and isolated as a brown solid
(27.5 mg, 56%). IR 3354, 2929, 2863, 1631, 1590, 1556, 1464, 1256, 1171, 1105,
836,778 cm-1; 1H NMR d 8.21 (s, 1 H), 7.77 (s, 1 H), 7.58 (m, 6 H), 7.44 (m, 2 H), 7.33
(m, 1 H), 6.17 (d, J = 7.0 Hz, 1 H), 5.36 (br, 2 H), 4.85 (dd, J = 4.8, 7.0 Hz, 1 H), 4.28
(dd 1 H, J = 2.2, 4.8 Hz, 1 H), 4.18 (d, J = 2.6 Hz, 1 H), 4.07 (dABq, J = 2.2, 11.7 Hz, 1
H), 3.89 (dABq, J = 2.8, 11.9 Hz, 1 H), 0.95 (s, 9 H), 0.85 (s, 9 H), 0.73 (s, 9 H), 0.16 (s,
3 H), 0.11 (s, 3 H), 0.02 (s, 3 H), -0.05 (s, 3 H), -0.05 (s, 3 H), -0.29 (s, 3 H);
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13

C NMR

d 152.5, 150.2, 150.2, 148.6, 140.9,138.2, 136.0, 129.0, 127.7, 127.0, 126.9, 120.9, 86.5,
86.4, 72.7, 72.1, 63.2, 26.3, 26.0, 25.6, 18.8, 18.25, 17.8, -4.4, -4.6, -5.0, -5.2, -5.4.
HRMS calculated for (M+ + 1): 777.4375, found: 777.4362.

NH2

NH2
N

N

NH
N

N

OTBS
O
TBSO

OTBS

N-(2’,3’,5’-tris-O-tert-butyldimethylsilyladenosin-8-yl)-benzidine
Prepared by the same procedure as N-(2’,3’,5’-tris-O-tertbutyldimethylsilyladenosin-8-yl)-aniline, using 8-bromo-2’,3’,5’-tris-O-(tertbutyldimethylsilyl)-adenosine (40 mg, 0.06 mmol), and benzidine (33 mg, 0.18 mmol).
30 Mol% Pd2(dba)3, and 50 Mol% BINAP were used. Purification was by flash
chromatography (1% MeOH /CHCl3 to 5% MeOH /CHCl3, rf 0.40 5% MeOH /CHCl3)
as a brown solid (28.7 mg, 60%). IR 3453, 3354, 3219, 3031, 2959, 2935, 2851, 1637,
1602, 1555, 1497,1467, 1253, 1156, 1106, 837, 776, 737; 1H NMR d 8.21 (s, 1 H), 7.68
(s, 1 H), 7.51 (dd, J = 8.6, 16.7 Hz, 4 H), 7.39 (d, J = 8.4 Hz, 2 H), 6.75 (d, J = 11.0 Hz, 2
H), 6.16 (d, J = 7.0 Hz, 1 H), 5.25 (br, 2 H), 4.86 (dd, J = 4.8, 7.0 Hz, 1 H), 4.28 (dd, J =
2.4, 4.6 Hz, 1 H), 4.17 (d, J = 2.6 Hz, 1 H), 4.05 (dABq, J = 2.4, 11.9 Hz, 1 H), 3.88
(dABq, J = 2.6, 11.7 Hz, 1 H), 0.95 (s, 9 H), 0.84 (s, 9 H), 0.73 (s, 9 H), 0.15 (s, 3 H),
0.11 (s, 3 H), 0.01 (s, 3 H), -0.05 (s, 3 H), -0.06 (s, 3 H), -0.30 (s, 3 H);

13

C NMR

d 152.4, 150.3, 150.2, 148.9, 145.7, 137.5, 136.5, 131.4, 127.7, 126.8, 120.9, 117.2,
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115.5, 86.4, 86.3, 72.4, 72.2, 63.1, 26.3, 26.0, 25.7, 18.8, 18.2, 17.8, -4.2, -4.4, -4.6, -5.1,
-5.2, -5.5. HRMS calculated for (M+ + 1): 792.4484, found: 792.4470.

NH2
N

N

NH
N

N
OTBS
O
TBSO

OTBS

N-(2’,3’,5’-tris-O-tert-butyldimethylsilyladenosin-8-yl)-2-aminofluorene
Prepared by a modified procedure (Wolf, J. P.; Buchwald, S. L. J. Org. Chem.
2000, 65, 1144-1157.). An oven dried Schlenk flask was purged with argon. A solution
of Pd(OAc)2 (4.0mg, 30 mol%) and BINAP (18.6mg, 50 mol%) in 5mL anhydrous
toluene was added and heated at 40 oC for 30 minutes. After the BINAP completely
dissolved 2-aminofluorene (32.6mg, 0.18 mmol), 8-bromo-2’,3’,5’-tris-O-(tertbutyldimethylsilyl)-adenosine (40mg, 0.06 mmol), and NaOtBu (8.0mg, 0.084 mmol)
was then added and the temperature was raised to 80 oC. After 5.5 hours the reaction was
complete by TLC and the reaction mixture concentrated. The crude material was purified
by flash column chromatography (eluted 0.5% MeOH in CHCl3) and isolated as a
greenish solid (12.0 mg, 25%). IR 3354, 2938, 2928, 2856, 1635, 1559, 1458, 1257,
1106, 836, 778; 1H NMR d 8.20 (s, 1 H), 7.83 (s, 1 H), 7.74 (m, 3 H), 7.53 (bd, J = 7.6
Hz, 1 H), 7.44 (dd, J = 2.0, 8.2 Hz, 1 H), 7.37 (dd, J = 7.1, 7.1 Hz, 1 H), 7.29 (dd, J =
1.1, 7.3 Hz, 1 H), 6.20 (d, J = 7.7 Hz, 1 H), 5.61 (br, 2 H), 4.81 (dd, J = 4.8, 7.3 Hz, 1 H),
4.26 (dd, J = 2.2, 4.8 Hz, 1 H), 4.18 (d, J = 2.2 Hz, 1 H), 4.08 (dABq, J = 2.6, 11.7 Hz, 1
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H), 3.90 (m, 3 H), 0.96 (s, 9 H), 0.83 (s, 9 H), 0.73 (s, 9 H), 0.15 (s, 3 H), 0.11 (s, 3 H),
0.01 (s, 3 H), -0.05 (s, 3 H), -0.07 (s, 3 H), -0.29 (s, 3 H);

13

C NMR d 151.5, 150.2,

149.4, 148.6, 144.4, 143.1, 141.5, 137.8, 137.5, 126.9, 126.3, 125.1, 120.6, 120.2, 119.6,
118.2, 117.1, 86.7, 86.3, 72.4, 72.3, 63.3, 37.1, 29.8, 26.3, 25.9, 25.6, 18.9, 18.2, 17.8, 4.3, -4.4, -4.5, -5.1, -5.2, -5.4. HRMS calculated for (M+ + 1): 789.4375, found
789.4377.
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CHAPTER 4. ADDUCT ANALYSIS BY HPLC
TANDEM MASS SPECTROMETRY
4.1 Introduction and Objective
The detection of DNA adducts is a daunting challenge. Their formation is rare
and the isolation of DNA as a sample matrix dictates that most samples will be small.
Yet because carcinogens have no threshold of safety for exposure, no observable level of
adverse effect, and exposure to a single molecule or “ one hit” may be enough to cause
uncontrollable cell division that is potentially fatal, it is important to detect them. Not
only do they need to be detected, but also their formation and repair needs to be studied,
and the complete mechanism of their carcinogenicity understood, in hopes that something
can be done to prevent their ill effects.
The detection of DNA adducts by HPLC electrospray ionization (ESI) tandem
mass spectrometry (MS/MS) offers several advantages that other methods do not posses.
This method offers the advantages of not requiring radioactive compounds, or hard to
obtain antibodies. It also provides specific qualitative information in the form of
molecular weights and characteristic fragmentation. Aside from serving as a useful tool
to study adduct formation and the mechanisms of tumor initiation, this method also
measures direct evidence of primary damage to DNA that measuring the tissue
concentration of the parent arylamines does not do. Measuring DNA adducts themselves
is thought to be a more precise and reliable way to determine the risks from carcinogen
exposure.91,92 Consequently the use of DNA adducts as bio-markers for risk assessment
and environmental monitoring is increasing.93
We have developed a qualitative and quantitative HPLC, ESI, MS/MS, isotope
dilution detection method to detect the C8 adenine adducts of benzidine and 2-
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aminofluorene. In order to demonstrate the validity of this method two separate spike
and recovery studies were performed.
4.2 Experimental Section
C8-Adenine adducts of per-deutero, and non-labeled 2-aminofluorene and
benzidine where prepared using our new method of palladium catalysis. C-18 Sep-Pak
cartridges were purchased from Waters (Milford, MA). All solvents used for LC/MS and
LC/MS/MS analysis were HPLC grade and purchased from Fisher Scientific (Itasca, IL).
All mobile phases contained 0.2% formic acid to assist in ESI positive ionization.
Separation was achieved using a Waters 2696 multisolvent delivery system equipped
with a Waters 2487 dual wavelength UV detector and an auto-injector. Reverse-phase
chromatography was performed using a Zorbax SB-CN column (250 x 4.6 mm, 5 µm)
purchased from MAC-MOD Analytical, Inc. (Chadds Ford, PA). The flow rate used was
1 mL/min. with a 1:1 split between the column and mass spectrometer. 0.2% formic acid
in water was used as solvent A, and 0.2% formic acid in acetonitrile was used as solvent
B with the following linear gradient program. 0 minutes, 100% A; 5 minutes, 100% A;
25 minutes, 100% B: 30 minutes 100% B; 35 minutes 100% A; 40 minutes 100% A.
Mass spectrometry was performed with a Micromass (Wythenshawe, UK) Quatro
II triple-quadrupole mass spectrometer using the electrospray ionization source in the
positive ion mode. Tuning of the ionization source and optimization of the MS/MS
parameters were carried out using non-labeled C8-adenine adducts of 2-aminofluorene
and benzidine. Roughly 5ng/µL standards were prepared in methanol containing 0.2%
formic acid and infused into the mass spectrometer with a syringe pump at a flow rate 10
µL/min. After the ESI interface was optimized and a general tune was performed on
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each adduct the optimum ionization voltage for each adduct was determined. This was
done by monitoring the intensity of the [M+H]+ ion (m/z 318, benzidine adduct, m/z 315,
2-aminofluorene adduct) over a 2.0 kV to 5.0 kV range of capillary voltages in 0.2 kV
increments. The collision energy was then optimized by monitoring the intensity of the
most abundant fragment ion produced from each parent ion. In this study the first
quadrupole of the mass spectrometer was set to pass only the parent ion, collisions were
induced in the central region with a gas cell pressure of ~2.5 x 10-3 mbar argon and a full
scan of fragment ions was acquired by the third quadrupole. Fragmentation of the
benzidine adduct was monitored over collision voltages from 0 to 125 V, and
fragmentation of the 2-aminofluorene adduct was monitored over voltages from 0 to 155
V as it required a higher fragmentation energy.
For the quantitative study of adducts a multiple reaction monitoring (MRM)
method was developed for each adduct and its labeled internal standard. This involved
passing only the molecular ion of the analytes (parent ions) through the first quadrupole,
fragmenting in the collision cell, and then passing only the two most abundant fragments
of each analyte (daughter ions) on to the detector. For the benzidine adduct the
transitions monitored were m/z 318 to 169 and m/z 318 to 208, for its labeled counterpart
they were m/z 326 to 175, and m/z 326 to 215. For the 2-aminofluorene adduct the
transitions monitored were m/z 315 to 166, and m/z 315 to 205, for its labeled
counterpart they were m/z 324 to 173, and m/z 324 to 205. A standard curve was
constructed by replicate analysis of 10 µL injections of standard solutions containing
from 0.1 ng/µL, 0.2 ng/µL, 0.4 ng/µL, 0.8 ng/µL, 1.6 ng/µL, and 3.2 ng/µL of adduct in
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DMSO. Each injection also contained 2 ng of the corresponding deuterated internal
standard. Blanks both with and without internal standard were also analyzed.
Two spike and recovery studies were performed to assess method validity, adduct
stability, and procedure efficiency. For the first study two sets of duplicate samples were
prepared by spiking 15, 75, 150, and 300 ng of authentic standards into separate test tubes
containing 2.5 mL of 0.02 N HCl. The solutions were then hydrolyzed for 1.5 hours at
75 oC. After cooling, each sample was neutralized to pH 7 with NaOH. Each sample
was then loaded on to a C18 Sep-Pak cartridge that had been activated by rinsing with 6
mL of acetonitrile followed by 6 mL of DI water. After loading each sample was washed
with 8 mL of DI water and then eluted with 3 mL of methanol. Each methanol sample
was then evaporated to dryness under ultra pure nitrogen and then spiked with 30 ng of
the appropriate internal standard dissolved in 50 µL of DMSO. The residue was then
redissolved in 100 µL of DMSO and submitted to LC/MS/MS analysis. For the second
spike and recovery study, two sets of duplicate samples were prepared by spiking 15, 75,
150, and 300 ng of authentic standards into separate test tubes containing 2.5 mL of 0.02
N HCl and 4mg of salmon sperm DNA. Each sample was then spiked with 30 ng of the
appropriate internal standard at this point rather than in the post Sep-Pak stage. The
solutions were then hydrolyzed for 1.0 hours at 75 oC. After cooling, each sample was
neutralized to pH 7 with NaOH. Each sample was then loaded on to a C18 Sep-Pak
cartridge that had been activated by rinsing with 6 mL of acetonitrile followed by 6 mL
of DI water. After loading each sample was washed with 8 mL of DI water and then
eluted with 3 mL of methanol. Each methanol sample was then evaporated to dryness
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under ultra pure nitrogen. The residue was then redissolved in 150 µL of DMSO and
submitted to LC/MS/MS analysis.
4.3 Results and Discussion
4.3.1 Standard Characterization and Ionization Optimization
To insure the purity of each standard a full scan of each adduct was taken over a
mass range of m/z 110 to 1000 by direct infusion. The ESI mass spectrum for the
benzidine adduct, and that of its deuterated form are seen in Figures 24. and 25.
respectively.

Figure 24. ESI mass spectrum of the benzidine adduct
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Figure 25. ESI mass spectrum of the benzidine-d8
The ESI mass spectrum for the 2-aminofluorene adduct, and that of its deuterated form
are seen in Figures 26. and 27. respectively. In all cases the [M+H]+ ion of the adduct is
clearly the most abundant ion present. In the case of the authentic adducts it is the
intensity of this ion that is monitored in order to optimize ionization.
In order to achieve the maximum sensitivity for our method it was necessary to
find which MS/MS conditions produce the strongest signal for detection. The mass
spectrometer has several parameters that must be tuned to insure that the analyte is
completely ionized and fragmented. Most of these parameters, including the skimmer
cone voltage, can be optimized by computer ramping programs. Two parameters that
must be manually optimized are the capillary ionization voltage and the collision voltage
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Figure 26. ESI mass spectrum of the 2-aminofluorene adduct

Figure 27. ESI mass spectrum of the 2-aminofluorene-d9 adduct
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used to induce fragmentation. The optimum ionization voltage for the benzidine adduct
was found to be 3.2 kV, and that of the 2-aminofluorene adduct was found to be 3.0kV.
The results of the ionization study for the benzidine adduct are shown in Figure 28. The
results for 2-aminofluorene are shown in Figure 29. It is possible that at lower voltages
Benzidine Adduct Ionization

Response of [M+H]+ 318
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Figure 28. The optimum ionization voltage of the benzidine adduct
reduced sensitivity is due to incomplete sample ionization, while at higher voltages it is
due to an arcing effect or sample decomposition.
To insure confirmation of each adduct the transition from its molecular ion to its
two most prominent fragments is measured by multiple reaction monitoring. To
determine which fragments to monitor and what collision energy is optimal, the first
scanning region of the spectrometer was set to pass only the molecular ion and the second
region was used for a full scan of fragments. The results of the benzidine adduct collision
study are seen in Figure 30.
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2-Aminofluorene Adduct Ionization
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Figure 29. The optimum ionization voltage of the 2-aminofluorene adduct
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Figure 30. The optimum collision voltage of the benzidine adduct
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120
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The optimum collision voltage for the benzidine adduct was found to be 38 V. The ESI
MS/MS mass spectrum of the benzidine adduct for these optimized conditions is
presented in Figure 31.

Figure 31. The ESI MS/MS mass spectrum of the benzidine adduct
To determine if these conditions were suitable for fragmentation of the labeled
standard, and which of its fragments should be monitored, it was also ran by infusion.
The ESI MS/MS mass spectrum of the deuterated benzidine adduct is presented in Figure
32. A logical assignment of these fragments can be seen in Figure 33. Because the
fragments of the deuterated adduct differ by a m/z of 7 and not 8 it is possible that during
fragmentation one of the deuterium ions is exchanged for a proton.

70

Figure 32. The ESI MS/MS mass spectrum of the benzidine-d8 adduct
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Figure 33. Structural fragments of the benzidine and benzidine-d8 adducts
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The results of the 2-aminofluorene adduct collision study are seen in Figure 34.
The optimum collision voltage for the 2-aminofluorene adduct was found to be 70 V.
The ESI MS/MS mass spectrum of the 2-aminofluorene adduct under optimized
conditions is seen in Figure 35. and that of the deuterated 2-aminofluorene adduct is seen
in Figure 36. A logical assignment of these fragments is presented in Figure 37. Again it
appears that deuterium/hydrogen exchange occurs during fragmentation as the deuterated
fragments differ by a m/z of 8 rather than 9.

Fragmentation of 2-Aminofluorene Adduct
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Figure 34. The optimum collision voltage of the 2-aminofluorene adduct
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155

Figure 35. The ESI MS/MS mass spectrum of the 2-aminofluorene adduct

Figure 36. The ESI MS/MS mass spectrum of the 2-aminofluorene-d9 adduct
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Figure 37. Structural fragments of the 2-aminofluorene and 2-aminofluorene-d9
adducts

4.3.2 Quantitative LC/MS/MS Detection Method
Before work was begun on the mass spectrometry method, a suitable HPLC
separation was found. Electrospray ionization and mass spectrometry place certain
requirements on the type of liquid separation technique they can be coupled with. Flow
rates must be kept low (<1ml/min.), so that the vacuum of the mass spectrometer can be
maintained. Solvents must be low boiling (<120 oC), so that they can be evaporated in
the ion source allowing the analyte to enter the mass spectrometer. Nonvolatile buffers
that would precipitate and block the source can also not be used. If an acid or base is
used to increase the ionization of the analyte it too must be volatile. For our method a
flow rate of 1ml/min. was used with a 1:1 split between the column and mass
spectrometer. This split reduced the flow rate into the mass spectrometer by half to
0.5ml/min. A linear gradient was developed using water and acetonitrile both containing
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0.2% formic acid was developed. With this gradient the benzidine adduct and its
deuterated internal standard co-eluted at 12.96 minutes and the2-aminofluorene adduct
and its deuterated internal standard co-eluted at 16.99 minutes.
To improve sensitivity, multiple reaction monitoring was employed for the
detection method. This technique improves sensitivity by only detecting specific ions of
interest. This is done in primarily two ways. The first is the benefit of removing any
interferences that would increase the background noise. The second benefit is that by
allowing the scanning regions to spend the entire analysis time on only the analytes of
interest, almost none of the signal is lost by spending time scanning other masses.
Conformational information is still retained because the ions that are monitored
correspond to the specific molecular ions, and their two most abundant fragment ions of
the desired analytes. The measurement of these two ions over time produces a
chromatogram with peaks corresponding to the concentration of analyte in the sample.
Representative chromatograms of the blank and standard solutions are presented in
Figure 38. A calibration curve was prepared from triplicate runs of authentic standard
solutions over a range of 1 to 32 ng (1, 2, 4, 8, 16, and 32ng) of adduct on column. Each
standard injection also contained 2 ng of deuterated internal standard. Peak height was
used rather than area as it gave a more accurate result.
The processed data used to construct the standard curve for the benzidine adduct
is presented in Table 5. A linear response versus concentration was determined (y =
0.8324x –0.1728) using the method of least squares with a resulting R2 of 0.9981 (Figure
39). Most of the standards were accurate. The overall percent accuracy of all standards
ranged from 92 to 112 % with the highest percent relative standard deviation ob 6.33%.

75

A

B

C

D

Figure 38. Representative chromatograms of blank and standard solutions of the
benzidine and 2-aminofluorene adducts. For each pair the top chromatogram is the
authentic standard response and the bottom chromatogram is the internal standard
response. A. Benzidine adduct blank B. 1 ng Benzidine standard C. 2aminofluorne blank D. 1 ng 2-aminofluorene standard
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Table 5. Benzidine Adduct Standard Data
Ng Adduct
On Column

Ng Adduct
Calculated

% Accuracy

1.00
1.00
1.00
2.00
2.00
2.00
4.00
4.00
4.00
8.00
8.00
8.00
16.00
16.00
16.00
32.00
32.00
32.00

1.11
1.10
1.08
2.01
2.03
2.24
3.83
4.29
4.10
8.01
8.15
8.16
14.92
14.67
15.22
32.04
32.62
32.82

111
110
108
100
102
112
96
107
102
100
102
102
93
92
95
100
102
103

Average
% Accuracy ±
Standard Deviation

% RSD

110 ± 1.2

1.10

105 ± 6.6

6.33

102 ± 5.8

5.71

101 ± 1.0

1.03

93 ± 1.7

1.85

101 ± 1.3

1.24

The limit of detection was pg (69 fmole) (S/N = 3) and the limit of quantitation was 73 pg
(230 fmole) (S/N = 10).
The processed data used to construct the standard curve for the 2-aminofluorene
adduct is presented in Table 6. A very linear response versus concentration was
determined (y = 0.5449x +0.1454) using the method of least squares with a resulting R2
of 0.9996 (Figure 40). The overall percent accuracy of all standards ranged from 89 to
106 % with the highest percent relative standard deviation being 6.06 %. The limit of
detection was 51 pg (162 fmole) (S/N = 3) and the limit of quantitation was 171 pg (543
fmole) (S/N = 10).
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Benzidine Adduct Standard Curve
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Figure 39. The standard curve for the benzidine adduct
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Table 6. 2-Aminofluorene Adduct Standard Data
Ng Adduct
On Column

Ng Adduct
Calculated

% Accuracy

1.00
1.00
1.00
2.00
2.00
2.00
4.00
4.00
4.00
8.00
8.00
8.00
16.00
16.00
16.00
32.00
32.00
32.00

0.93
0.89
0.97
2.13
1.89
2.08
4.18
3.91
4.01
8.52
8.35
8.45
16.42
16.35
15.48
31.36
31.89
32.31

93
89
97
106
95
104
105
98
100
106
104
106
103
102
96
98
100
101
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Average
% Accuracy ±
Standard Deviation

% RSD

93 ± 4.2

4.49

102 ± 6.2

6.06

101 ± 3.5

3.46

106 ± 1.1

1.04

100 ± 3.5

3.45

100 ± 1.5

1.49

2-Aminofluorene Adduct Standard Curve
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Figure 40. The standard curve for the 2-aminofluorene adduct

4.3.3 Spike and Recovery Studies
In order to demonstrate the method validity, adduct stability, and procedure
efficiency two separate spike and recovery studies were performed. The first determined
the adduct stability to acid hydrolysis and the efficiency of Sep-Pak C18 cartridge
recovery. The second spike and recovery study demonstrated the effect of a biological
matrix, in this case DNA, on adduct recovery, and determined if any natural interferences
were present.
For the stability and recovery study the internal standard was added to the
evaporated residue after the Sep-Pak filtration in order to insure a constant value. The
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recovery of the benzidine adduct spike varied greatly ranging from 39-95 % recovery,
with an average of 68% (Table 7).
Table 7. Stability Study of the Benzidine Adduct

Ng Benzidine
Adduct Spike

Ng Benzidine
Adduct
Calculated

Recovery
(%)

Average
Recovery

1.00
1.00
5.00
5.00
10.00
10.00
20.00
20.00

0.90
0.91
4.69
4.58
9.21
8.98
18.21
18.44

90
91
94
92
92
90
91
92

91
93
91
92

The recovery of the 2-aminofluorene adduct spike also varied greatly ranging from 40119 % recovery, with an average of 78% (Table 8).
Table 8. Stability Study of the 2-Aminofluorene Adduct

Ng 2-Aminofluorene
Adduct Spike

Ng 2-Aminofluorene
Adduct
Calculated

Recovery
(%)

Average
Recovery

1.00
1.00
5.00
5.00
10.00
10.00
20.00
20.00

0.96
0.97
4.75
4.81
9.69
9.48
19.24
19.07

96
97
95
96
97
95
96
95

97
96
96
96

The fact that all samples were hydrolyzed for the same amount of time and eluted with
the same amount of methanol make it unlikely that this variance is due to standard
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decomposition or Sep-Pak retention. It is more likely that the 150 µL of DMSO used to
redissolve the sample was inefficient at taking up the entire sample. The 3 mL eluents
were collected in 4 mL glass vial and evaporated under ultra pure nitrogen. Although
after the DMSO was added, all the vials were vigorously vortexed for 30 seconds, it is
possible that random amount of the spike had absorbed near the rim of each vial
preventing it from reincorporating into the sample. In order to overcome this the second
spike and recovery study concentrated each sample in a 1.5 mL vial in 1 mL batches
including a 1 mL rinse of fresh methanol. Representative chromatograms of blank and
spiked samples are presented in Figure 41.

A

C

B

D

Figure 41. Representative chromatograms of blank and recovery/stability samples.
For each pair the top chromatogram is the authentic spike response and the bottom
chromatogram is the internal standard response. A. Benzidine adduct blank B. 1
ng Benzidine spike C. 2-aminofluorne blank D. 1 ng 2-aminofluorene spike

The results for the DNA spike and recover experiment samples are much
improved over the stability/efficiency study. Average recoveries were much higher and
contained much less variance. The recovery of the benzidine adduct in the DNA samples
ranged from 96-114 % recovery, with an average of 105% (Table 9).
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Table 9. DNA Recovery Study of the Benzidine Adduct

Ng Benzidine
Adduct Spike

Ng Benzidine
Adduct
Calculated

Recovery
(%)

Average
Recovery

1.00
1.00
5.00
5.00
10.00
10.00
20.00
20.00

0.96
0.99
5.31
5.49
10.18
11.43
21.36
20.95

96
99
106
110
102
114
107
105

98
108
108
106

The recovery of the 2-aminofluorene adduct in the DNA samples ranged from 95-117 %
recovery with an average recovery of 105 % (Table 10).
Table 10. DNA Recovery Study of the 2-Aminofluorene Adduct

Ng 2-Aminofluorene
Adduct Spike

Ng 2-Aminofluorene
Adduct
Calculated

Recovery
(%)

Average
Recovery

1.00
1.00
5.00
5.00
10.00
10.00
20.00
20.00

0.95
0.99
5.71
5.09
11.65
10.31
20.06
21.86

95
99
114
102
117
103
100
109

97
108
110
105

This improved recovery is due to two primary factors. The first is that the internal
standard underwent the entire sample procedure along with the non-labeled authentic
adduct spike. Thus if any material was lost a proportional amount of the internal standard
was also lost to make up for it. The second factor, which may be even more significant is
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that the evaporation and re-concentration step was performed in smaller vials allowing
for complete re-incorporation of the sample residue.
Representative chromatograms of blank and 1 ng adduct spikes in DNA samples
are presented in Figure 42.
A

C

B

D

Figure 42. Representative chromatograms of blank DNA and DNA spike samples.
For each pair the top chromatogram is the authentic spike response and the bottom
chromatogram is the internal standard response. A. Benzidine adduct blank B. 1
ng Benzidine spike C. 2-aminofluorne blank D. 1 ng 2-aminofluorene spike

From Figure 42. B. it can be seen that the retention time of the benzidine adduct has been
shifted from 12.99 minutes to 13.58 minutes. This is due to the vast abundance of nonadducted nucleotides from the DNA sample that coelute in this region. The presence of
this interference has changed the partitioning of the analyte between the moble and
stationary phases This interference can be seen by the online UV detector set at 300nm
between the HPLC column and the mass spectrometer in Figure 43. The large
interference peak shifts the retention time of the benzidine adduct by altering its partition
coefficient between the stationary and mobile phase. Although the retention time has
changed due to the interference, the sensitivity of the MS detector is not affected. This
can be seen in the low background of Figure 43. B. Altering the HPLC gradient so that

84

the benzidine adduct would not coelute with the interference would produce a consistent
retention time. It may also be possible to remove the interference during the C18
concentration step by performing additional washes before eluting.
A

B

Figure 43. UV and benzidine adduct MRM response of a DNA blank. A. The UV
response at 300 nm. B. The MRM response of the benzidine adduct. The top
chromatogram corresponds to the response of the authentic adduct and the bottom
corresponds to that of the internal standard.

In conclusion, we have developed a sensitive method for the detection of
benzidine and 2-aminofluorene C8 adenine adducts in DNA with random efficiency. The
average limit of detection was ~100 fmole which would correspond to one adduct in ~6 x
107 bases for a 4 mg DNA sample, well within physiologically relevant levels. Our
sample preparation procedure has an average recovery of 105 %.
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CHAPTER 5 CONCLUSION
In summary we have developed a new synthetic method involving a palladium
catalyst for the synthesis of C8-adenine arylamine adducts. This method was used to
prepare adduct of several arylamine in yields of 25-84 %. Some of the adducts were then
used as standards in LC/MS/MS detection method. A standard curve was constructed for
the benzidine C8-adinene adduct having an R2 = 0.9981 with a limit of detection of 22 pg
(69 fmole) (S/N = 3), and a limit of quantitation of 73 pg (230 fmole) (S/N = 10). A
standard curve was constructed for the 2-aminofluorene C8-adenine adduct having an R2
= 0.9996 with a limit of detection of 51 pg (162 fmole) (S/N = 3), and a limit of
quantitation of 171 pg (543 fmole) (S/N = 10). This method was then validated by two
spike and recovery studies that demonstrated adduct stability, detection efficiency, and
the lack of interferences.
Our synthetic method is a great improvement over existing techniques to prepare
adducts. Other methods typically result in yields of less than 5 % and require preparative
HPLC. Our method allows for the preparation of adducts in a few easy steps on a scale
readily sufficient for characterization by NMR. Although our method was unsuccessful
for producing C8-guanine adducts it is likely that it could be, with the incorporation of
extra protective and deprotective steps. As it is, the significance of minor C8-adenine
adducts compared to more common C8-guanine adducts, is much less studied, in part due
to the difficulties of preparing standards. Our method overcomes this obstacle. Our
method is also likely to be useful in preparing adducts of substituted methylene dianiline
compounds that are known to produce C8-adenine adducts predominantly.
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Our LC/MS/MS method has shown to be very sensitive, capable of detecting one
adduct per ~6 x 107 bases of DNA. This sensitivity is sufficient for the detection of
adducts at physiological levels. This method is applicable for quantifying C8-adenine
adducts of benzidine and 2-aminofluorene from in vitro and in vivo studies. It could be
used to correlate arylamine exposure to adduct formation frequency, or the kinetics of
adduct formation and repair. It could also be used as a diagnostic method to screen for
DNA damage in environmental and industrial settings. By slightly changing the multiple
reaction monitoring of the mass spectrometer this method could be modified to detect
other arylamine adduct isomers, though quantitation would not be as precise. Current
work is being conducted to improve recovery reproducibility.
Overall this work has contributed to the study of arylamine carcinogenicity. Both
our synthetic and analytical methods have numerous applications for future studies in this
field. The possibilities of heteroatom organometalic catalysis, and LC/MS/MS are
virtually limitless and research in both areas should be continued in order to better
understand the world around us, and our interaction in it.
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APPENDIX
H1 NMR Spectra

N-(2’,3’,5’-tris-O-tert-butyldimethylsilyladenosin-8-yl)-4-aminobiphenyl
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N-(2’,3’,5’-tris-O-tert-butyldimethylsilyladenosin-8-yl)-benzidine
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N-(2’,3’,5’-tris-O-tert-butyldimethylsilyladenosin-8-yl)-2-aminofluorene
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